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ABSTRACT

A NON-INVASIVE DIAGNOSTIC SYSTEM FOR EARLY ASSESSMENT OF ACUTE
RENAL TRANSPLANT REJECTION
Mohamed Nazih Mohamed Ibrahim Shehata
July 15, 2016

Early diagnosis of acute renal transplant rejection (ARTR) is of immense importance for appropriate therapeutic treatment administration. Although the current diagnostic
technique is based on renal biopsy, it is not preferred due to its invasiveness, recovery time
(1-2 weeks), and potential for complications, e.g., bleeding and/or infection.
In this thesis, a computer-aided diagnostic (CAD) system for early detection of
ARTR from 4D (3D + b-value) diﬀusion-weighted (DW) MRI data is developed. The
CAD process starts from a 3D B-spline-based data alignment (to handle local deviations
due to breathing and heart beat) and kidney tissue segmentation with an evolving geometric
(level-set-based) deformable model. The latter is guided by a voxel-wise stochastic speed
function, which follows from a joint kidney-background Markov-Gibbs random field model
accounting for an adaptive kidney shape prior and for on-going visual kidney-background
appearances. A cumulative empirical distribution of apparent diﬀusion coeﬃcient (ADC)
at diﬀerent b-values of the segmented DW-MRI is considered a discriminatory transplant
status feature. Finally, a classifier based on deep learning of a non-negative constrained
stacked auto-encoder is employed to distinguish between rejected and non-rejected renal
transplants. In the “leave-one-subject-out” experiments on 53 subjects, 98% of the subjects
were correctly classified (namely, 36 out of 37 rejected transplants and 16 out of 16 nonrejected ones). Additionally, a four-fold cross-validation experiment was performed, and
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an average accuracy of 96% was obtained. These experimental results hold promise of the
proposed CAD system as a reliable non-invasive diagnostic tool.
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CHAPTER I
EXISTING TECHNIQUES FOR THE ASSESSMENT OF RENAL REJECTION: A
SURVEY

The kidney is a very important complicated filtering organ of the body. Many complications and diseases can arise in this organ. One such disease is chronic kidney disease
(CKD), which is a gradual loss of function of the nephrons. When the kidney reaches stage
5 chronic kidney disease, end stage renal failure, the preeminent therapy is renal transplantation. Although it is the best form of treatment, the dearth of kidney donors is still
challenging. Therefore, all eﬀorts should be employed to prolong the survival rate of the
transplanted kidney. However, graft dysfunction (e.g., acute rejection) is one of the serious
barriers to long term kidney transplant survival. Currently, graft dysfunction’s gold standard of diagnosis is renal biopsy. Although renal biopsy is helpful, it is not preferred due to
its invasive nature, high morbidity rates, and expensiveness. Therefore, noninvasive imaging techniques have become the subject of extensive research and interest, giving strong
promise to replace, or at least to decrease, biopsy usage in diagnosing graft dysfunction.
This chapter will discuss not only the kidney anatomy, chronic kidney disease, treatment,
and current diagnosis but also the state-of-the-art imaging techniques in diagnosing graft
dysfunction.
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A. Introduction
The kidney is a very important organ. It is the main filtration organ in the human
body, keeping the nutrients that the body needs in and expelling the waste that can become
toxic. Maintaining the health of this organ is critical. There are diseases that can cause
the kidney to decrease in function such as diabetes, hypertension, glomerular disease, and
polycystic kidney disease [3]. These can cause a gradual loss of function in the kidney leading to waste build up in the body and the patient to develop chronic kidney disease (CKD).
CKD aﬀects about 26 million people with 17,000 transplants being performed each year
in the U.S. [4, 5]. Though this has greatly improved the outcome of patients diagnosed
with stage 5 CKD, complications can still arise. One of the main concerns is graft dysfunction. Routine post-transplantation clinical evaluation of kidney function is of immense
importance to prevent the graft loss. The diagnostic technique currently recommended by
the National Kidney Foundation (NKF) to measure overall kidney function is Glomerular
Filtration Rate (GFR), which is based on measuring the serum creatinine level. However,
this test has low sensitivity and is a late marker for renal dysfunction (a significant change
in serum creatinine level is detectable only after the loss of 60% of renal function), and
it does not assess the function of individual kidneys. The current gold standard for diagnosing diﬀerent types of kidney dysfunction is needle biopsy [6]. However, this can be
diﬃcult, costly, and time-consuming. Renal biopsy can also result in complications such as
infections, bleeding, and at times, death. With the evolution of computer-aided diagnostic
(CAD) systems, we hope to non-invasively diagnose diﬀerent types of graft dysfunction,
saving time and money. This chapter will give an overview on how CKD is treated and
kept viable in post-transplantation when it is aﬀected by graft dysfunction. Thus, the need
for new noninvasive techniques which have the capability to provide accurate diagnosis of
kidney dysfunction is of great clinical importance.
This chapter presents an overview of current clinical techniques for renal transplant
function evaluation as well as an examination of new ways to improve the detection of
graft dysfunction using image-based technology [7]. The rest of this chapter is organized
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as follows: Section I.B provides a brief overview of the anatomy and function of the kidney. Section I.C takes a closer look at who is more at risk for developing CKD and some
symptoms associated with it. In addition, an overview of the treatment options for people
that develop stage 5 CKD will be given, concentrating on transplantation as a definitive
therapy. Section I.D takes a look at follow-up post transplantation care, which includes
possible complications that could arise with a concentration on graft dysfunction. Section I.E will concentrate on tests that are performed to detect graft dysfunctions including
the traditional methods such as blood, urine, and renal biopsy. This is followed by the
image based techniques such as ultrasound, and magnetic resonance imaging (MRI).

B.

Kidney Anatomy and Function

As stated before, kidneys are the main filtration system in the body. Kidneys are
able to keep nutrients like salts, sugar, and protein in, while at the same time expelling
excess nutrients, water, and waste such as urea and ammonia out of the body. Kidneys
keep human bodies in a homeostatic state. They regulate the blood’s pH, blood pressure,
and osmolality. Osmolality is the amount of particles of solutes that are dissociated in a
solvent [8]. Each kidney is shaped like a bean and is about the size of a fist [9] and weighs
about 150 g [10]. They are located in the lower back below the rib cage.
As shown in Figure 1, the kidney is composed of an outer ”shell”, which is the renal
cortex; an inner layer, the renal medulla; and a hollow area where the urine is collected,
the renal pelvis [10] . Inside the cortex and medulla are the filtration units known as the
nephrons (see Figure 2), which are then made up of smaller subunits such as the glomerulus,
vasa recta, and loop of Henle [10]. Since the kidneys must filtrate the blood, they must be
connected to veins and arteries. The kidneys are connected to the renal artier and vein
which are connected to the iliac artery and vein, respectively. That is the general overview
of the anatomy of the kidneys, now this chapter will trace the filtration pathway of the
blood. The blood enters the kidney by way of the renal artier. Once there, the blood moves
to the nephrons of the cortex where the blood then enters the aﬀerent arteriole which allows
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FIGURE 1: Coronal cross-section of a normal kidney with labeled anatomy.
the blood to enter in the glomerulus. The glomerulus is then able to filter out waste through
the assistance of blood pressure. This waste is filtered into the Bowman’s capsule. From
the Bowman’s capsule the waste moves to the proximal tubule then to the Loop of Henle
and thin segment, which can be found in the medulla. At these places in the nephron, more
filtration can be done. From here, waste moves to the distal tubule then the collecting tubule
and finally into the renal pelvis. The waste that ends up in the renal pelvises will then move
through the ureter to the bladder and then out of the body by way of the urethra. The clean
blood exits the glomerulus by way of the eﬀerent arteriole. Once there, more filtration can
be done in the Peritubular capillaries where the blood could also move down the Vasa recta
in the medulla; nutrients that were filtered out by the loop of Henle and thin segment can
be resorbed there. The blood then exits through the venules and then through the arcuate
veins, and finally leaves the kidney through the renal vein. The clean blood can then travel
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FIGURE 2: A nephron structure with labeled anatomy and pathway of filtration.
back to the heart [10]. As one can see, this organ is very complex and with this complexity
many problems can arise. In the next section this chapter will discuss what can go wrong
and who is at risk of developing these complications.

C. Renal Problems/Symptoms and Treatment
The renal system is a very complex system, in which various complications and
diseases can arise pertaining to it, especially with the kidney. There are multiple conditions and/or diseases that can arise in the kidney such as kidney stones, injury, infections,
and cancer. The focus of this chapter will be on CKD, the 9th leading cause of death in
America [11]. CKD is a gradual loss of function of the kidney, where the nephrons become
compromised [4]. To date, 26 million people in the U.S. are living with CKD [4]. The
risk of developing CKD could be increased due to a few diﬀerent factors such as various
physiological conditions, diseases, age, race, lifestyle, and family history. Conditions that
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increase the likelihood of developing CKD include diabetes, high blood pressure, heart disease, and high cholesterol [12]. People with the following diseases are at increased risk of
CKD; HIV, Hep C, Metabolic syndrome, cancer, and sickle cell trait [13]. Individual 65
years or older are also more at risk. African Americans tend to also have a greater risk compared to the rest of the population [12]. Lifestyles that increase risk include obesity [14]
or smoking [12]. The last risk factor is family history; if a patient has a parent or family
member with CKD they have a greater chance of developing the disease [12]. People with
these risk factors should be aware and contact their doctor if any of the following symptoms
become present. In early stage CKD the patient may be asymptomatic but as the disease
progresses, kidney function will worsen and symptoms will develop. Symptoms can include change in urination, whether it changes in frequency, feeling, color, or texture. The
urine can also start to contain blood [15]. Apart from the change in urination, symptoms
can include limb swelling, iron build up that can cause nose bleeds and bad breath [15]. As
the disease progresses infection-like symptoms can arise [16]. CKD can have an eﬀect not
only on the body but also on mental state and activity level. These symptoms can include
fatigue, generalized weakness, decreased libido, change in memory [16], and a decline in
mental function [15]. More rare but more serious symptoms may include rash, generalized
pain, chest pain, and shortness of breath [15–18]. If a patient should have any of these last
symptoms, he/she should seek immediate medical attention. Every patient is diﬀerent and
there is no set relationship between symptoms and the stage of the patient’s kidney disease
[16]. As stated before, if one should develop any of these symptoms, he/she should talk to
their doctor about checking for CKD. If left untreated, symptoms could worsen and kidney
failure will advance to stage 5 CKD. The untreated patient with stage 5 CKD could die due
to the build up toxins in the body. To prevent this from happening, the patient should be
treated with dialysis or transplantation.
Luckily, there have been developments in treatments for patients with stage 5 renal
failure. Those treatments include blood dialysis or renal transplant. Blood dialysis is when
one’s blood is filtered of waste or excess water, either with use of a machine outside the
body (hemodialysis) or chemically inside the body (Peritoneal Dialysis) [19]. Though
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dialysis is a helpful treatment, a more long term treatment would be kidney transplantation.
This is where a donor’s kidney is surgically inserted into the CKD patient. That new kidney
should improve filtration for the patient. Since transplantation is the definitive therapy
for End-Stage Renal Disease (ESRD), the following describes in more detail the kidney
transplantation procedure and associated complications and diseases.
As previously stated, renal transplantation is a surgical procedure where a donated
kidney is placed inside the patient with CKD. However, it does not mean that a nephrectomy
(i.e. removal of the malfunctioned kidney) is performed on the patient with CKD. The
patient with CKD usually gets to keep both of the kidneys, unless those kidneys are causing
pain or other complications [20]. This means that the patient will have three kidneys after
the procedure. The donated kidney also has its own ureter, renal artery, and vein intact.
The donated kidney is placed below (distal of) the native kidneys with the donated ureter
connecting to the bladder, and the renal artery and vein connecting to the iliac artery and
vein of the patient, respectively [21]. Figure 3 demonstrates the entire anatomy of a patient
renal system after transplantation.
This procedure seems fairly simple in concept. However, the process to find that
donor can be fairly complicated not only medically and logistically but also due to legal
hurdles. There are two diﬀerent types of donors that can be used for CKD; cadaver and
living donors. Only one third of the transplantations are from living donors while two thirds
of the transplantations are from cadaver donors [22]. Often, the physician and the CKD
patient must decide whether to use a living or a cadaver kidney. Often a more desirable
choice would be to have a living donor give one of their kidneys. However, this is not
without its complications. The donor must meet all criteria such as being HLA (+or−)
and/or ABO compatible, physically in good health, and be in no way coerced against their
will to donate [22, 23]. This means that the donors can back out at any time. This is why
even if there is a willing living donor the physician may persuade the patient to get on the
United Network of Organ Sharing (UNOS) [24]. Depending on where the patient is on the
list determines if and when they will receive a donor. The donated kidneys from this list
are from cadaver donors. In order for the cadaver’s kidney to be viable the kidney must
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FIGURE 3: Anatomy of renal system of a patient after kidney transplant.
be functioning before death and the manner of death must not damage the organ. Also the
time and location of death may play a part since the kidney must not decompose before the
kidney can be donated [22]. In the United States, the living donors must be willing to give
up their kidney, cadaver donors must also make it clear that they are willing to be a donor
after death. With all of these criteria, it is no wonder that although there are about 17,000
kidney transplants performed annually in the United States, there are still about 100,800
people waiting for a kidney. With this in mind, it is very important that the transplanted
kidney is kept viable as long as possible so that a nephrectomy and repeat transplantation do
not have to be performed [5]. In the following section, an overview on what happens during
post-transplantation care should be given, which in turn should improve the viability of the
organ post-transplantation. This includes follow up procedures and the complications that
arise for transplant patients.
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D. Post-Transplant Follow-Ups and Complications
Just as with any medical procedure complications can arise such as infection and
bleeding. so one must remain in constant care of one’s physician. They must continue
follow ups to insure that the new kidney is functioning and that new complications do not
arise. To prevent new complications from arising, the patient should follow the instructions
of their physician by taking their anti-rejection medications and visiting their physician as
directed [25]. The frequency at which a patient has to visit their physician will decrease as
time after transplantation increases. Once the patient has reached 210 days post-operatively,
they should be seeing their physician monthly or if abnormalities arise [26]. During those
clinical visits various tests such as examining the patient’s weight, blood pressure, and
temperature will be done to assess both the overall health of the patient and the health of
the kidney. The urine and the blood tests will be discussed later in this chapter. If these
tests appear abnormal, the physician may order a renal biopsy and/or scans [27]; both will
be discussed in greater detail later on in the chapter. For now, this chapter will concentrate on the complications that can arise during these tests, specifically those complications
that are associated with (renal) transplants. This Section will take a look at those types
and concentrate specifically on graft dysfunction. First, this chapter will explain types of
complications other than graft dysfunction.

1. Types of Complications
There are six categories of complications including: urological complications, vascular complications, fluid collection, neoplasms, recurrent native renal disease, and graft
dysfunction. This section will take a short look at the first five complications then the
next section will go a little more in depth for graft dysfunctions. The term urological
complications generally refers to uncontrolled or obstructed urine flow [28, 29]. Vascular
complications are complications that are associated with the vascular system of the renal
system, i.e. renal or iliac artery/vein. Vascular complications can include narrowing, blockage or formations of holes in the vascular system [30]. Fluid collection is closely related
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to urological complications and/or vascular complications in that if there is a urological or
vascular complication, fluid such as blood or urine will collect in areas where they are not
supposed to be collecting. This will create urinomas hematomas, abscesses, or lymphoceles [29–31]. Neoplasms are abnormal growth such as tumors that grow on the renal system
and other areas. This is said to be caused by the prolonged exposure to immune repressor
drugs [30, 32, 33]. Lastly, recurrent native renal disease is when the disease that caused the
patient to develop CKD in the first place, such as diabetes, is now aﬀecting the donated
kidney [34, 35]. It is possible for the patient to develop a combination of these complications. It is important that for any of these complications, diagnosis and treatment are done
as soon as possible. Most of these complications are usually easier to detect as compared
to graft dysfunction. This is because these complications can be detected using various
imaging techniques such as ultrasounds and MRIs [36]. These imaging techniques will
be discussed later on in this chapter but the concentration will be more on graft dysfunction. The complication and cause that is more challenging to diagnose is graft dysfunction,
which shall be examined next.

2.

Graft Dysfunction
Graft dysfunction simply means that the newly transplanted organ is no longer func-

tioning, toxins then build up, and the body rejects the transplanted organ [30]. It was calculated that within the first five years post transplantation, 15% of patients will experience
graft dysfunction [37]. There are three classes of graft dysfunction: hyperacute, acute, and
chronic. The type of graft dysfunction is diﬀerentiated by the mechanism and somewhat
by the time of dysfunction onset [38]. Hyperacute rejection is relatively rare nowadays.
This class of rejection is caused by antibodies attacking the donated organ due to the donor
organ having the wrong HLA (+or−) and/or ABO blood antigen and will present itself
within in minutes or hours after transplantation [23]. There is no cure for hyperacute rejection [39]. Chronic kidney rejection’s mechanism is not well understood but appears to
present itself after five years post-transplant [23]. The main concentration in this chapter
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will be on Acute Kidney Rejection (AKR). Just as there are diﬀerent types of complications in renal transplant, there are diﬀerent causes of graft dysfunction. This can provide
somewhat of a challenge in diagnosis and treatment. This is due to the fact that there is
a diﬀerent treatment for each cause of graft dysfunction. There are four diﬀerent causes
of graft dysfunction; they include: acute tubular necrosis (ATN) antibody-mediated rejection, T-cell mediated rejection, immunosuppressive toxicity (ITox), and viral infection
(VI). ATN is when the antibodies of the patient recognize the newly donated kidney as a
foreign body causing the tissue to become necrotic and die. It is treated with a drug therapy
regimen that may include plasmapheresis, mycophenolate mofetil, and tacrolimus [40–42].
T-cell is when killer T-cells attack the donated organ causing apoptosis in the tissue [38].
The treatment for T-cell mediated rejection includes drugs such as corticosteroids, antithymocyte globulin, and immunosuppression therapy. If the patient has antibody-mediated
rejection, they may not respond to the T-cell mediated rejection treatment [43–45]. Immunosuppressive toxicity is when the immunosuppressive drugs that are supposed to be
preventing the immune system from rejecting the donated kidney actually cause renal failure since these drugs can be nephrotoxic. Treatment for this would be to cease or change
the medication, cease, or to reduce the dose of the nephrotoxic drug such as Cyclosporine
and tacrolimus [46–48].VI is when viruses such as Cytomegalovirus or Herpes simplex
virus enters the body and damages the kidney [49]. Treatments for VI may include administering immunosuppressant and/or antiviral medications [40]. The causes of AKR can be
presented singularly or in combination, which can add to the diﬃculty in diagnosing the
cause of AKR. How the cause of these graft dysfunctions are diagnosed will be discussed
in the next section of this chapter.

E. Detection/Assessment of Renal Rejection
It is important that the patient keeps regular visits with their physician in order to
ensure that their newly transplanted organ is in working order. The post-transplantation
follow-ups’ main concern is to keep the graft viable for as long as possible. If the patient
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continues regular follow-ups and notifies the physician of any symptoms that arise, it is
possible that they can catch the problem early and save the donated organ. This chapter will
give an overview of the existing techniques/methods for diagnosing graft dysfunction. This
includes both traditional, non-imaging, clinical methods, and the imaged-based techniques
that are in use but are still being developed and/or improved for use. More details about
both methods are given below.

1.

Traditional Methods
Traditionally, during a routine follow-up a blood and urine analysis will be imple-

mented. If there are any abnormal results in either of these, the physician may order a renal
biopsy to get a definitive diagnosis. This diagnosis should also tell the physician what
is causing the kidney malfunction. This next section will show how these diagnoses are
determined. First, this chapter will discuss urine testing.
a. Urine Tests This method is very simple in use. It can test for multiple substances and is non-invasive. Using the patients urine, the physician is able to measure a
number of biomarkers to determine GFR. Most often the biomarker used to calculate GFR
is serum creatinine. To calculate GFR, the concentration of creatinine found in the urine
sample is placed into an equation which has constants that change based on sex, race,
and age. Using the calculated GFR, one is able to determine what stage of function the
kidney(s) are in, 0 being at an increased risk and 5 being end stage renal failure [50, 51].
This diagnostic technique is currently recommended by the NKF to measure overall kidney
function. However, this test has low sensitivity and is a late marker of renal dysfunction (a
significant change in serum creatinine level is detectable only after the loss of 60% of renal
function), and it does not assess the function of individual kidneys [6]. The next test that
shall be discussed will be a blood test.
b. Blood Test/Works This method is similar to urine in that it measures estimated GFR using serum creatinine. However, since it does pierce the skin when obtaining
the blood, this test is slightly more invasive. A complete blood count and diﬀerential count
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(CBC and diﬀ) [52] measure more substances than urine including detecting the presence
of burred blood cells which can be present in patients with CKD. Burr cells are blood cells
that appear almost gear like. They appear when there is an excess amount of waste in
the body, which is likely to happen in patients with CKD [53, 54]. Though it has slightly
more benefits than a urine test, it has the similar setback in that the test has low sensitivity
and is a late marker of renal dysfunction and it does not assess the function of individual
kidneys [6]. The last traditional method that shall be discussed is a renal biopsy.
c. Biopsy (Gold Standard) Renal biopsy is a traditional method for the graft
function assessment that is by far the most invasive, but to date is considered the gold
standard. This procedure is performed using a renal biopsy needle that is inserted into the
patient’s back and kidney while being guided by a camera, ultrasound, or x-ray, as shown
in Figure 4 [52]. The tissue that is obtained is read using a microscope [55]. The patient is
fully conscious and asked to hold their breath and to not move [52]; if one should breathe
or move, they run the risk of piercing other organs. Along with the risk of piercing other organs the patient also runs the risk of excessive bleeding and infections. Excessive bleeding
can present itself more so in a patient who is on blood thinners. Infections are likely to occur since the patient is more than likely on an immunosuppressive therapy regimen [37, 56].
These complications can lead to nephrectomy or even death; both occur in 1 in every 1,000
renal biopsies [37].
Along with the invasiveness of the procedure, there are multiple setbacks that are
associated with this procedure. Renal biopsies, although a useful tool, have the tendency to
give a missed diagnosis or inaccurate estimate of the extent of the problem. This is because
it is only sampling a small portion of the kidney and if oﬀ target in the slightest can miss
an eﬀective portion of the kidney and give a false negative. This would mean that a repeat
biopsy may have to be performed causing the patient more pain and precious time lost in
order to save the graft. On the subject of time, the time it takes to obtain the results can
take up to two weeks [57]. That time which could be used for treatment is wasted and
can result in failure of the donated kidney. On top of these setbacks, the financial cost of
the procedure can reach over ($20,000) [58]. So this test cannot only cause physical pain
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FIGURE 4: Illustration of ultrasound-guided renal biopsy procedure.
but also create more of a financial burden. Though these tests have been routinely used
for transplant assessment and have helped in improving graft survival, one can see that
there needs to be a better way to diagnose and diﬀerentiate the cause of graft dysfunction.
Additionally, existing techniques, i.e. GFR and biopsy, for diagnosis of renal rejection
are late biomarkers. Moreover, renal biopsy has significant morbidity, is very expensive,
takes up to two weeks to get the final report, and can result in over- or under-estimation
problems by only sampling small areas of the kidney. Therefore, the development of noninvasive tests to monitor kidney transplant rejection status is of immense importance. This,
in turn, will allow doctors to intervene early to prevent rejection and the damage it causes,
which will improve long-term outcomes. The following section will overview existing
non-invasive imaging techniques and their possible use for assessing renal function and
diagnosing graft dysfunction. In this chapter, the imaging techniques that will be discussed
are ultrasound and MRI.
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2.

Image-Based Techniques for Renal Transplant Evaluation
The development of computer-aided diagnosis (CAD) systems for renal transplant

assessment using diﬀerent imaging modalities is an ongoing area of increased research.
Non-invasive imaging-based techniques have been clinically used to assess transplanted
kidneys with the advantage of providing information on each kidney separately. For example, radionuclide imaging (also called scintigraphy), the traditional method in renal imaging, is an excellent modality for evaluating graft function, both qualitatively and quantitatively, while also screening for common complications [59]. However, this technique
fails to show accurate anatomical details due to its limited spatial resolution, so functional
abnormalities inside diﬀerent parts of the kidney (such as cortex and medulla) cannot be
discriminated precisely [60]. Furthermore, radionuclide imaging includes radiation exposure [61], thus limiting the range of its applications, especially in monitoring such diseases as ATN or cyclosporin [62]. Computed tomography (CT) is a commonly available
technology that uses contrast agents that allows accurate evaluation of various diseases in
renal transplantation and with lower costs than magnetic resonance imaging (MRI) [63].
However, information gathered by CT to detect renal acute rejection is unspecific and the
contrast agents used still are nephrotoxic. Therefore, currently CT has a limited role in diagnosing acute renal rejection [64]. In contrast to these radionuclides and CTs, ultrasound
(US) and MRI are the most popular imaging modalities used for the diagnosis of kidney
diseases. In the following sections, an overview of diﬀerent CAD systems for the diagnosis
of acute renal rejection using these two imaging modalities is given.

3. Ultrasound (US) Imaging
Ultrasound (US) imaging is usually used for the early assessment of renal allografts
functionality in the postoperative period as well as for the assessment in the long-term
follow-up thanks to being a relatively easy to be performed and repeated, inexpensive, and
non-nephrotoxic imaging modality. [9]. Pulsatility index (PI) and resistance index (RI) are
the most common measurements to assess renal functionality using US. Some recent stud-
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ies that assessed renal transplants using diﬀerent forms of ultrasound (e.g., power doppler
(PD), color doppler (CD), contrast enhanced (CE), etc.), please see Figure 5) are discussed.

FIGURE 5: An example of diﬀerent ultrasounds.
In an investigation to characterize the factors that influence PI and RI in patients
with immediate (IGF), slow (SGF), or delayed (DGF) kidney graft function, Chudek et
al. [65] observed that ischemic injury which occurred mainly prior to organ harvesting
played a dominant role in determining intra-renal resistance in the early post-transplant
period. A study by Saracino et al. [66] investigated whether the long-term renal functionality could be predicted using RI measurements taken early after kidney transplant.
On the other hand, Kramann et al. [67] concentrated in their study on evaluating the potential of RI measurements to predict renal allograft survival. They concluded that, for
prediction of long-term allograft survival, RI measurements should be taken 12-18 months
post-transplantation. Krejčı́ et al. [68] utilized a composite gray-scale, CD imaging, and
PD imaging to examine the power of US for early detection of a subclinical acute rejection.
A significant diﬀerence between the four diﬀerent groups in their study was obtained. In
another study by Damasio et al. [69], the ability of doppler US to diﬀerentiate between dual
and single kidney transplantation (DKT) and (SKT), respectively, was exploited. After the
measurement of RI parameters for both DKT and SKT groups, they concluded that those
patients with DKT had higher RI and lower kidney volumes than those with (SKT).
A study by Shebel et al. [70] investigated the ability of PD in the diﬀerentiation
between acute rejection (AR) and ATN. Their study included 67 renal transplant recipients
in the early post-transplantation period. After a manual placement of regions of interest
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(ROIs), cortical perfusion (CP) and RI were measured for all recipients and CP was tested
with respect to serum creatinine (SCr) and RI. Upon their own CP grading scale system,
they found a statistical significant correlation between their CP grading and SCr (P <
0.01) and between CP grading and RI (P < 0.05). They concluded that the PD using CP
grading is more sensitive in the detection of early AR compared to RI and cross-sectional
measurements.
Fischer et al. [71] proved the superiority of ultrasound contrast media (USCM) to
conventional US that uses the RI indicator in the diagnosis of early allograft dysfunction. In
addition, Benozzi et al. [72] found that both US and CEUS could identify grafts with early
dysfunction, but only some CEUS derived parameters could diﬀerentiate between ATN and
AR. Schwenger et al. [73] exploited the power of CE sonography (CES) in early prediction
of long-term renal transplant functionality compared to CD ultrasonography (CDUS). In
their study, 68 renal transplants were investigated using both CES and CDUS one week
after transplantation. Renal blood flow (RBF) and RI were measured for all transplant
recipients and were correlated with the recipients’ clinical data represented by glomerular filtration rate (GFR) in a post-transplantation period from one week to one year. They
concluded from their observations that RBF measurement using CES was significantly correlated with kidney functionality in the aforementioned period after transplantation, in contrast with RI measurement using CDUS. Another study was explored by Göcze et al. [74]
to diﬀerentiate between acute kidney injury (AKI) stages using CEUS based on the quantification of blood perfusion. Instead of generating time-intensity curves (TIC), they used
another quantification method called arrival time parametric imaging (ATPI). Their study
included 10 patients who underwent CEUS, of which four patients had no evidence of AKI,
one with stage AKI, and five with stage 2 or 3 AKI. Color-maps based on inflow time (IT)
of the contrast agent were generated using the CEUS-ATPI quantification method and were
divided into six major categories based on their values. Then, these ITs were assessed for
diﬀerent poles of kidney cortex (i.e. lower, middle, and upper) and the total IT was the sum
of all arrival times of these three poles for each kidney. They observed that patients with
stage 2 or 3 AKI have more delayed ITs than those of the other groups. They concluded
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that CEUS-ATPI technique may help in detecting diﬀerent stages of AKI. Recently, Jin et
al. [75] assessed renal allografts using CEUS. In their study, 57 renal transplant patients
underwent CEUS. Then, they were divided into three groups: 23 patients with AR (group
1), 10 patients with ATN (group 2), and 24 patients with normal allografts (group 3). After
a manual placement of ROIs, a new index to detect AR called rising time (RisT) was measured instead of arrival time (AT). In addition, time to peak (TTP) and delta time among
ROIs (∆RisT and ∆TTP) were measured, analyzed, and correlated with clinical data (e.g.,
GFR). They found that RisT, TIP, and (∆RisT and ∆TTP) were significantly higher in group
1 as compared to those in group 2 and group 3.
Although several studies utilized US to evaluate and assess renal functionality preand post-transplantation by evaluating conventional ultrasound parameters such as the PI
and RI, two contradictory studies [76, 77] concluded that RI is not an exact indicator of
renal graft dysfunction, and it could only provide a prognostic marker of the graft. Moreover, doppler US may give high PI and RI values (>0.8), which is an indication similar to
those of ATN [78, 79]. These contradictions led researchers and investigators to examine a
diﬀerent imaging modality to asses renal functionality (e.g., MRI). In the next section, the
state-of-the-art studies utilizing diﬀerent MR imaging modalities are discussed.

4.

Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging (MRI) has become the most powerful and central non-

invasive tool for clinical diagnosis of diseases [80]. The main advantage of MRI is that it
provides excellent morphological information and oﬀers the best soft tissue contrast among
all imaging modalities (e.g., US and CT), which allows advanced analysis of diﬀerent aspects of renal function. However, structural MRI lacks functional information. On the
other hand, other MRI modalities, such as dynamic MRI, BOLD MRI and diﬀusion MRI
are frequently used for renal function evaluation. Next, the state-of-the-art studies utilizing
these MRI modalities for renal transplant assessment are overviewed.
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a. Dynamic Contrast Enhanced (DCE) MRI: Dynamic MRI of the kidney has
gained considerable attention in assessing renal function due to its ability to characterize
tissue-specific functional changes, and potential to measure both total and cortical volume,
and other functional parameters such as RBF, GFR, and renal plasma flow (RPF). Therefore, in recent years several studies have exploited DCE-MRI to non-invasively analyze
kidney function in both native and transplanted kidneys. Figure 6 shows an example of
DCE-MRI before, during, and after the administration of contrast to the kidney.

FIGURE 6: Illustrative example of a DCE-MRI sequence with pre-, post-, and latecontrast.
In particular, a study by de Priester et al. [81] utilized dynamic MR enhancement
curves to qualitatively evaluate diseased (27 patients) and nondiseased (8 patients) renal
transplants. Cortical and the medullary enhancement parameters were obtained from a
physiological model that was fitted to the raw data. Cortical arterial blood volume and
medullary wash-out rates were found as the main discriminatory parameters between diseased and nondiseased patients. Yuksel [82] introduced a DCE-MRI-based CAD system
for the evaluation of transplant function, which employed deformable image segmentation,
kidney registration, and cortical perfusion construction. After kidney segmentation, a manual cortical ROI is used to construct the perfusion curve from the co-aligned images and the
kidney function is evaluated visually based on the pattern of the constructed curves. Automated CAD system for early diagnosis of acute transplant rejection by Farag et al. [83]
and El-Baz et al. [84–86] included parametric deformable model segmentation, nonrigid
alignment, and classification of the kidney status using empirical parameters. Their frameworks were tested on 30 data sets and classified kidney status of each patient using four
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indexes: the peak signal intensity, the time-to-peak, the wash-in slope (slope between the
peak and the first minimum), and the wash-out slope (peak and the signal measured from
the last image in the sequence), calculated from the MRI signal for the kidney cortex. A
supervised Bayesian classifier was employed and the system classified 13 out 15 and 15
out of 15 correctly for both training and testing, respectively. Similar approaches were
proposed in [87–89]. The study utilized a global alignment step of the MR images exploiting a special Gibbs energy function, and the perfusion curves were estimated from the
whole kidney rather than only the cortex. The latter CADs were tested on a larger cohort
of 100 patients and achieved a 94% diagnostic accuracy using Bayesian supervised classifier. A semiautomated approach by Rusinek et al. [90] assessed cortical and medullary
functional parameters (RPF, GFR, vascular volumes of the cortex and medulla, and rate
of water absorption) using compartmental modeling for both simulated and in-vivo data.
Their framework employed an initial rigid alignment (translation only) step followed by a
graph-cut based segmentation approach. The system was tested on 22 clinical data sets and
the study concluded that the accuracy and precision in RPF and GFR are acceptable for
clinical use.
Zikic et al. [91] evaluated kidney kinetic parameters after motion correction using
template-matching based registration and normalized gradient field (NGF), as the contrastinvariant similarity measure. However, the kidney was segmented manually, and the evaluation of perfusion parameters (plasma volume and tubular flow) was performed visually
by trained physicians for 10 data sets of healthy volunteers. Semi-automated evaluation of
renal function for both native and transplanted kidneys was explored by De Senneville [92]
using rigid-body registration to handle kidney motion inside a user-defined ROI. The renal
cortex was segmented manually, and the GFR was estimated with Patlak-Rutland tracer
kinetic model. The study demonstrated a significant uncertainty reduction on the computed GFR for native kidneys (10 healthy volunteers), but not the transplanted ones (10
transplant patients). Aslan et al. [93] developed an automated CAD system to classify
normal kidney function from kidney rejection using DCE-MRI. Following kidney segmentation, three classification methods (least square support vector machines (LS-SVMs), Ma-
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halanobis distance, and the Euclidean distance) were compared to assess transplant status
based on medullary perfusion curves. On a cohort of 55 clinical data sets, they a achieved a
diagnostic accuracy, sensitivity, and specificity of 84%, 75%, and 96%, respectively using
the Mahalanobis distance-based classifier. Anderlik et al. [94] proposed a framework for
quantitative assessment of kidney function using a two-step motion correction and pharmacokinetic modeling. The GFR was estimated from the time-intensity curves using Sourbron
et al. [95] compartment model. Their framework has been tested on 11 data sets. Zöllner et
al. [96] employed a non-rigid registration using B-splines and mutual information (MI) as
a similarity metric. Functional information was extracted regionally using k-means clustering [97]. This system was tested on only 4 DCE-MRI data sets and the evaluation of kidney regions was assessed qualitatively according their mean signal intensity time courses.
Wentland et al. [98] utilized MRI-based intrarenal perfusion measurement to diﬀerentiate
between normal-functioning kidney allografts and allografts with ATN or AR on a cohort
of 24 biopsy proven patients. The study concluded that the cortical and medullary blood
flow is significantly reduced in grafts experiencing AR, as compared with normal grafts.
Additionally, AR patients demonstrated medullary blood flow reduction as compared with
ATN patients.
Recently, a study by Abou El-Ghar et al. [99] explored the feasibility of DCE-MRI
in evaluation of renal allograft dysfunction. Their CAD system employed computer based
techniques for motion correction and creation of renographic curves. Functional evaluation
on 55 patients using the mean medullary intensity a achieved sensitivity, specificity and
accuracy of 75%, 96% and 84%, respectively, to separate of normal kidneys from impaired
ones. Yamamoto et al. [100] utilized dynamic MRI to prospectively assess its ability to
identify the cause of acute graft dysfunction. Their study employed 60 patients, 31 of which
had normal function and 29 had acute dysfunction due to AR. Their study employed a multicompartmental tracer kinetic model to estimate the GFR and mean transit time (MTT)
at diﬀerent compartments of the kidney. The study document diﬀerences in the fractional
MTT values between normal grafts or grafts undergoing AR or ATN; however, substantial
overlaps among these groups and with normal kidneys were observed. Semi-automated
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estimation of renal parameters was performed by Hodneland et al. [101]. A viscous fluid
model combined with an NGF-based cost function was used for elastic kidney registration. However, the kidney was segmented interactively with the nearest neighbor approach,
the framework was tested only on 4 data sets of two healthy volunteers, and the reported
GFR measurements were slightly underestimated relative to the creatinine reference values.
Positano et al. [102] proposed a CAD system for the estimation for renal parameters, which
included a two-step rigid registration, and adaptive prediction of kidney position over the
course of the respiratory cycle. The perfusion indices (peak signal intensity, MTT, initial
up-slope, and time to peak) were evaluated on perfusion curves extracted from the automatically and manually registered data sets and were similar as well. An automated framework
for the classification of kidney transplant status was proposed by Khalifa et al. [103, 104].
In their framework, the kidney was segmented using a stochastic geometrical deformable
model approach and the local motion of the kidney was corrected for by a Laplace partial
diﬀerential equation-based nonrigid alignment method [105, 106]. Their initial study [103]
included only 26 data sets, and a K-nearest neighbor classifier was used. Their system
achieved a 92.31% correct classification using the time-to-peak and wash-out slope empirical parameters that are estimated from the agent kidney kinetic curves. Their framework
was extended in [104] by using four augmented empirical parameters (peak intensity value,
time-to-peak, up-slope and average plateau) by the genetic algorithm [107]. Unlike [103],
the parameters were derived from the cortex rather than from the whole kidney and the
system was tested on 50 patients, and the overall diagnostic accuracy increased to 96%
Another study by Khalifa et al. [108] extended the work in [103, 104] by using analytical
function-based model to fit agent cortical kinetic curves. For the classification of kidney
status, five features (three were derived from the gamma-variate functional model and two
are from the perfusion data, namely the time-to-peak and average plateau) were chosen and
the study included 50 transplant patients.
Although DCE-MRI has been employed as a widespread imaging technique to develop several CAD systems for renal transplants assessment purpose, the contrast agents
may implicate nephrogenic systemic fibrosis; thus, many medical centers are reluctant in
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applying the DCE-MRI to patients with renal disease [109]. In order to circumvent this
major drawback, DW-MRI and BOLD-MRI have been recently exploited to assess renal
transplants as they do not involve any use of contrast agents, like DCE-MRI. A brief discussion of recent renal transplant assessment studies using BOLD-MRI follows as well as
a discussion on other studies that utilized DW-MRI to assess renal transplants.
b. Blood Oxygen Level Dependant (BOLD) MRI: In addition to DCE-MRI,
another imaging technique, called BOLD-MRI, has been utilized to study renal rejection
using the amount of oxygen diﬀused blood (i.e. oxygen bioavailability) in the kidney to
determine whether it is functioning properly. Specifically, the amount of deoxyhemoglobin
is measured by the apparent relaxation rate (R2*) parameter [110]. Figure 7 shows grey
images and R2* color-maps for a normal kidney and a kidney with graft dysfunction.

FIGURE 7: A simple demonstration of grey and R2* colored images for a normal kidney
and a kidney with graft dysfunction.
In particular, Djamali et al. [111] investigated the ability of BOLD-MRI to assess
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renal allografts. In their study, 23 patients underwent BOLD-MRI scans, of which 5 were
normal allografts and 18 had acute allograft dysfunction (5 with ATN and 13 with AR).
Medullary and cortical ROIs were placed, and mean cortical (CR2*), medullary (MR2*),
and medullary to cortical (MCR2*) were calculated. They found that MR2* and MCR2*
values of patients with ATN and AR were significantly decreased more than those with
normal allografts. However, no diﬀerences in CR2* values between the diﬀerent groups
were observed. In a similar study by Han et al. [112], BOLD-MRI was conducted to
diﬀerentiate between patients with AR and ATN after transplantation. Their study included
110 patients, 82 with normal allografts (group 1) and 28 with kidney dysfunction, including
21 with AR (group 2) and 7 with ATN (group 3). Group 2 was divided into two subgroups:
13 patients with T-cell-mediated rejection (TMR) and 8 patients with antibody-mediated
rejection (AMR). Manual ROIs were placed in the cortical and medullary regions, and
CR2*, MR2*, and MCR2* were compared between diﬀerent groups. They performed a
statistical analysis, and they found that values of CR2*, MR2*, and MCR2* of group 2
were reduced compared to those of the other two groups. Contradictory to the Djamali
et al. [111] study, they found that values of MR2* of group 3 were higher than those of
group 1. However, no significant diﬀerence was observed between the TMR and AMR
subgroups.
Sadowski et al. [113] employed BOLD-MRI to assess kidney transplants. Manual
cortical and medullary ROIs were placed on 17 patients who underwent BOLD-MRI scans,
and these patients were divided into three groups: 5 patients with normal allografts (group
1), 4 with ATN (group 2), and 8 with AR (group 3). The MR2* and CR2* were calculated
in the same way as was done in their previous study [111], and compared between the
diﬀerent groups. Specifically, MR2* values of group 3 allografts were decreased compared
to those of group 1 and group 2, while no significant diﬀerence was observed in MR2*
values between group 1 and group 2. However, no diﬀerence was detected in CR2* values
among the three groups. Another interesting study by Liu et al. [110] was investigated to
detect renal allograft rejection using BOLD-MRI. A total number of 50 patients with renal
allografts were included and divided into three groups as 35 patients with normal allografts
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(group 1), 10 patients with AR (group 2), and 5 patients with ATN (group 3). After cortical
and medullary ROIs placement, CR2* and MR2* were measured to assess the three groups.
Group 2 had the lowest MR2*, while no significant diﬀerence was detected in CR2* values
among the three groups.
Although BOLD-MRI is a valuable imaging technique that has been investigated
by some researchers in detecting renal allografts dysfunction, BOLD-MRI remains challenging, not only because of the low signal-to-noise ratio (SNR) and the weakness of the
electromagnetic fields [114], but also the limited applicability of renal BOLD-MRI due to
kidney motions and susceptibility induced by bowel gas which may lead to impaired image
quality [115].
c. Diﬀusion-Weighted (DW) MRI: Recently, DW-MRI has become a subject of
extensive research as an emerging imaging modality for renal function assessment thanks
to DW-MRI’s ability to provide both anatomical and functional information, while avoiding
radiation exposures (like CT) and contrast agents administration (like DCE-MRI). For DWMRI, its functional parameter, called apparent diﬀusion coeﬃcient (ADC), is estimated
from diﬀerent gradient field strengths and duration (b-values), as shown in Figure 8, to
describe the unique tissue characteristics of inner spatial water behavior [115]. Therefore,
several studies have utilized DW-MRI to assess renal functionality by measuring the ADC
values, but the results have varied [110].

FIGURE 8: A demonstration of a DW-MRI sequence at diﬀerent b-values.
Eisenberger et al. [116] investigated the manually placed ROIs in the upper, middle,
and lower poles of the cortex and medulla on several slices to cover large regions of the allograft. Means and standard deviations of the ADC from all b-values were measured. The
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ADC combines the perfusion free ADC and microcirculation parameters, quantified with
perfusion fraction, Fp . These parameters were significantly reduced in the cortex and the
medulla for the AR and ATN cases, and their values correlated with the creatinine clearance
(CrCl). Similarly, a recent study by Hueper et al. [117] included 64 patients with renal allografts, of which 33 were patients with initial graft function (IniGF) and 31 were patients
with DGF. These patients underwent DW-MRI scans at two b-values (0 and 600 s/mm2 ).
After placement of manual ROIs and estimation of renal diﬀusion parameters, including
ADC and Fp , they concluded that renal diﬀusion parameters were significantly reduced in
patients with DGF and their values well correlated with renal function and renal allograft
fibrosis in biopsy specimens. The feasibility of diagnosing the acute renal transplant rejection (ARTR) from the DW-MRI was evaluated by Xu et al. [118] on 26 biopsy-proven
rejection and 43 non-rejection patients. The non-rejection patients showed higher ADCs
than those of the rejection group, and also demonstrated the best sensitivity and specificity
at the b-value of 800 s/mm2 , as was evinced by the ROC curve. Palmucci et al. [119]
evaluated functionality of 21 transplanted kidneys by comparing the estimated ADCs and
true diﬀusion (TD) with renal function indices. Patients were divided into three groups by
their CrCl values. The cortical ADC and TD were evaluated in a user-defined ROI of the
transplanted kidney for the three groups. A moderate positive correlation between the CrCl
and both the ADC and TD, as well as no diﬀerence between the ADC and TD values for
the adjacent groups, has been found. The subsequent extension [120] of these evaluations
to 35 patients revealed a slightly smaller positive correlation than the previously reported
one [119]. However, acute rejection responses after transplantation could not be detected.
Vermathen et al. [121] assessed renal functionality by determining long-term (3
years) stability and potential changes for renal allograft recipients. After selecting cortical
and medullary ROIs, the ADC had been calculated from all b-values. For good allograft,
a significant correlation between diﬀerent ADC components was observed, whereas for
reduced allograft, the Fp values were the highest, and the medullary Fp had the greatest
changes. Katarzyna et al. [122] investigated possible relations between the selected laboratory results and diﬀusion parameters in the early period after kidney transplantation by mea-
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suring additional exponential ADCs to overcome the DW-MRI T2-“shine-through” [123].
The measurements were conducted in the kidney’s cortex and medulla over multiple userdefined ROIs at the b-values of 600 and 1000 only. According to relative variability of
results and SNR, the best-quality ADC measurement in the renal cortex was at the b-value
of 1000 s/mm2 . Also, there were strong dependencies between the ADC and exponential ADC, measured in the renal cortex at b1000 s/mm2 , and the estimated GFR. Kaul et
al. [124] assessed the renal dysfunction with cortical and medullary ADC maps. They reported a significant decrease in the ADC values of medullas compared to those of cortexes
in normal donor kidneys and normally functioning transplanted kidneys. Both the medulla
and cortex ADCs decreased or increased significantly for a rejection or the recovery from
the rejection itself, respectively. A recent study by Abou-El-Ghar et al. [125] included 70
renal allograft patients who underwent DW-MRI scans at two b-values (0 and 800 s/mm2 ).
In this case, 49 patients had stable renal allograft function (group 1) and 21 patients had
acute graft impairment (group 2: 10 acute cellular rejection (ACR), 7 ATN, and 4 ITox rejection types). An ROI was placed at the middle of the kidney in a single cross-section and
a pixel-wise ADC was calculated. They have shown that the ADC values of group 1 were
significantly higher than those of group 2, and no overlap was detected between the ADCs
of group 1 and the ATN patients of group 2. However, the minimal overlap was observed
between the ADCs of group 1 and the patients with the ACR and IT of group 2. Recently,
Liu et al. [110] detected an early renal allograft dysfunction caused by AR and ATN using
the DW-MRI and BOLD-MRI with manually selected cortical and medullary ROIs. Their
study revealed lower values of both the measured apparent relaxation rates and ADC for
the AR group than for the control groups, and no diﬀerence in the ADC values for the AR
and ATN groups. A similar earlier study was conducted by Thoeny et al. [126].
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F. Chapter Summary
Though the treatment of chronic kidney disease has improved greatly with the use
of transplants, there are still challenges such as graft dysfunction that provide a challenge
in maintaining survival of the new organ. In the future, the use of image-based diagnosis
will be improved and implemented in the diagnosis of both pre- and post-transplantation. It
is hoped that by having these improved imaged based CAD systems that diagnosis of graft
dysfunction, along with the cause of graft dysfunction, will be less invasive, more accurate,
time saving, and inexpensive compared to renal biopsies and other traditional methods of
diagnosis. By having all of these advantages it is expected that graft survival will improve
in cases of graft dysfunction.

G. Thesis Organization
This thesis is presented in three chapters. The scope of each chapter is summarized
as follows:

1. Chapter I
This chapter overviews the existing traditional clinical methods and the current
image-based techniques which are used to evaluate and assess renal transplants functionality and to detect early signs of graft dysfunction. Additionally, a brief overview is given
in this chapter including: kidney anatomy and functionality, the risk of developing chronic
kidney disease (CKD) and some symptoms associated with it, an overview of the treatment options for people that develop stage 5 CKD, transplantation procedure as a definitive
therapy for these people with stage 5 CKD, and post transplantation follow-ups which includes possible complications that could arise with a concentration on graft dysfunction.
This is followed by the traditional tests that are performed to detect graft dysfunctions
such as blood, urine, and renal biopsy. Finally, the state-of-the-art image based techniques
which are used in renal transplants’ evaluation and assessment are discussed. These im-
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age techniques include: ultrasounds (US) (e.g., conventional, power doppler (PD), color
doppler (CD), contrast enhanced (CE), etc.) , and magnetic resonance imaging (MRI)(e.g.,
dynamic contrast enhanced (DCE), blood oxygen level-dependent (BOLD), and diﬀusionweighted (DW)).

2.

Chapter II
This chapter presents a new computer-aided diagnostic (CAD) system for the early

detection of acute renal transplant rejection (ARTR) using diﬀusion-weighted (DW) MRI.
The developed CAD system demonstrates multiple novelties including: (i) segmenting kidneys from the DW-MRI data in a fully automated mode using geometric deformable models; (ii) describing kidney functionality with the cumulative distribution function (CDF) of
the ADCs; and (iii) discriminating between rejection and non-rejection renal transplants
with a deep neural network learned by stacking layers of several auto-encoders with nonnegativity constraint (NCAE).

3. Chapter III
This chapter concludes the thesis, highlights the main contributions and obtained
results, and discusses the trend for possible future avenues to be handled.
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CHAPTER II
COMPUTER-AIDED DIAGNOSTIC SYSTEM FOR EARLY DETECTION OF ACUTE
RENAL TRANSPLANT REJECTION USING DIFFUSION-WEIGHTED MRI

A. Introduction
Due to the fact there are up to 17,000 renal transplants per annum in the U.S. and
a limited number of donors [127], the salvage of a transplanted kidney is of serious clinical concern. The immunological response of a patient’s body to a transplanted kidney,
called the acute renal transplant rejection (ARTR), is considered to be the leading cause of
renal dysfunction [127] after the transplantation. An early detection of renal dysfunction
increases the survival rate of the transplanted kidney [110, 125], as confirmed by clinicians.
Therefore, calling for essential medical biomarkers to assess renal transplants, especially at
an early stage, (i.e. before major changes in creatinine clearance (CrCl) and serum plasma
creatinine (SPCR) are detected), is very necessary to distinguish the ARTR from other
diagnoses, including the acute tubular necrosis (ATN) and immune drug toxicity.
Traditional blood tests and urine sampling to evaluate renal transplant dysfunction
cannot assess function of individual kidneys. The glomerular filtration rate (GFR) is based
on measuring the serum creatinine level and has been approved by the National Kidney
Foundation (NKF) to evaluate the overall kidney function. The GFR is a relatively imprecise and late marker for renal dysfunction (a significant change in creatinine levels is only
detectable after losing 60% of renal function) [6]. Biopsy, which remains the gold standard
for renal transplant assessment, is an invasive procedure with a high cost and morbidity rate,
and relatively small needle biopsy samples may over- or under-estimate an inflammation
extent in the entire graft [127]. More favorable non-invasive imaging tests provide separate information on each kidney. However, the most frequent scintigraphy, preferred for
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its good functional information, has too low spatial resolution [128] and exposes patients
to a small dose of radioactivity because of reliance on gamma-cameras [129]. Computed
tomography provides superior functional and anatomical information, but uses nephrotoxic
contrast agents and exposes patients to radiation as well [128]. These shortcomings have
been circumvented recently by evaluating kidney functions with magnetic resonance imaging (MRI). For example, the dynamic contrast-enhanced (DCE) MRI has been exploited for
renal function assessment due to providing both anatomical and functional kidney information [91, 92, 96, 109]. However, because the contrast agents may cause the development
of nephrogenic systemic fibrosis, many medical centers are reluctant in applying the DCEMRI to patients with renal disease [101].
In order to circumvent this major drawback, diﬀusion-weighted (DW) MRI has been
exploited as an emerging imaging modality for renal function assessment. The DW-MRI
measures unique tissue characteristics of inner spatial water behavior, namely, its apparent
diﬀusion coeﬃcients (ADC). In this chapter, a CAD system for the early detection of ARTR
using DW-MRI is developed, thanks to DW-MRI’s ability to provide both anatomical and
functional information, exposes patients to no radiation, and needs no contrast agents, like
the DCE-MRI. The proposed CAD system demonstrates multiple novelties including: (i)
segmenting kidneys from the DW-MRI data in a fully automated mode (Section II.B.1);
(ii) describing kidney functionality with the cumulative distribution function (CDF) of the
ADCs (Section II.B.2); and (iii) discriminating between kidney rejection and non-rejection
with a deep neural network learned by stacking layers of several auto-encoders with nonnegativity constraint (NCAE) (Section II.B.3). Section II.A.1 below briefly outlines stateof-the-art techniques in DW-MRI segmentation, followed by Section II.A.2 which reviews
the prior work on assessing the renal transplant function using the ADCs.

1.

Prior Work on DW-MRI Segmentation
The process of segmenting kidneys from the DW-MRI has not been addressed yet.

In literature, only known applications to other anatomical structures, such as the brain, the
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prostate, and the liver, can be reviewed.
Brain segmentation. To segment the brain tissue in a fully automated mode, Yap et al. [130]
used voxel-wise compartmental coexistence modeling of various diﬀusion features. After
possible signal contributions from diﬀerent brain tissues are assigned to each voxel using
diﬀusion exemplars, each voxel is classified in accordance with the least fitting residual.
Mujumdar et al. [131] segmented stroke lesions by using the Chan-Vese [2] deformable
boundary guided with the Mumford-Shah functional. An automated window-based noise
suppression at high b-values was conducted to enhance local contrast of the candidate lesions. Automated region growing by Saad et al. [132, 133] integrated homogeneity criteria
and simple statistical regional features, such as the mean signal intensity and the number of
pixels. However, both this approach and its semi-automated variant could not fully characterize the tumor lesion. Saad et al. [134] explored an automatic brain lesion segmentation,
which starts from the DW-MRI normalization, background removal, and enhancement.
Then both regional and boundary information, combined with statistical texture descriptors extracted from a collected gray level co-occurrence matrix, were used to guide the
segmentation of brain lesions (e.g., hyperintense or hypointense). To segment near-tubular
fiber bundles from the DW-MRI, Niethammer et al. [135] performed global statistical diffusion orientation modeling that utilized optimal paths or simple streamlining to obtain
geometric information. Convex approximation of the probabilistic Chan-Vese energy [2]
was employed using region-based directional statistics.
Prostate segmentation. McClure et al. [136] used geometric (level-set-based) deformable
boundaries and nonnegative matrix factorization (NMF) for an automated prostate segmentation from the DW-MRI. The NMF integrated the DW-MRI intensity, a prostate shape
prior, and pairwise spatial interactions between the prostate voxels. The like segmentation
and maximum a posteriori decisions were used by Firjani et al. [137] for early detection of
prostate cancer. An unsupervised level-set-based prostate segmentation by Liu et al. [138]
applies a shape penalty term described by an elliptical deformable boundary to initialize
and constrain the level-set function. The latter is then refined by connectivity and morphological analysis. Subsequently, their framework was extended to account for the 3D ADC
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images derived from the original DW-MRI [139]. After an initial coarse segmentation,
a shape prior weighting parameter is selected automatically, and refining morphological
operations are performed to obtain the final segmentation map. Ozer et al. [140] tuned
thresholds of support vector machines (SVM) and relevance vector machines (RVM) to
classify “multispectral” MRI data, e.g., dynamic MRI, quantitative T2 MRI, and DW-MRI,
for automated prostate segmentation in accordance with an user-defined performance criterion, such as optimal accuracy, maximal sensitivity, etc. Then, the best performance was
obtained by using a first-order polynomial kernel in the SVMs and RVMs. A fuzzy Markov
random field (MRF) modeling of the like multispectral MRI prostate data allowed Liu et
al. [141] to simultaneously perform an unsupervised prostate segmentation and MRF parameter estimation.
Liver segmentation. Veeraraghavan et al. [142] applied simultaneous segmentation and iterative registration to the liver DW-MRI data. At each iteration, the rigid global aﬃne
registration is followed by the the fine non-rigid B-spline-based registration. A sequence
of transformations is used to most accurately align the individual b-value images to the
reference image, the modified Housdorﬀ distance (MHD) being a similarity metric. Then,
a GrowCut optimization segments the whole volume of interest after one or more 2D slices
were manually segmented in the reference image. Stephen et al. [143] developed a semiautomated lesion segmentation and ADC estimation. For every given set of patient images,
a large rectangular ROI is created only once manually by the analyst in one of the images,
ensuring that the lesion is within the ROI in all of the images for all the b-values and some
pixel within the lesion region is marked as a seed. For each image, an empirical probability distribution pixel intensities inside the ROI is approximated with a finite Gaussian
mixture (FGM), a Markov-Gibbs random field (MGRF) model is built to quantify spatial
pixel-to-pixel dependencies (interactions), and these two statistical descriptors are combined to segment the lesion within the ROI for each image. To improve the segmentation,
geometric convexity constraints of a lesion are taken into account. A semi-automated joint
liver segmentation and alignment framework by Veeraraghavan and Do [144] begins from
a sequential least-squares alignment of the images. Then various structures in a randomly
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selected reference image are manually segmented, starting from user-drawn lines on these
structures. The closest image, selected with mean-shift tracking and aligned to the reference image using non-rigid B-spline-based deformations, is selected as the new reference
image, and the process is repeated for all remaining images in the sequence. Jha et al. [145]
developed an automated statistical clustering approach for segmenting liver lesions. The
DW-MRI intensity distribution is approximated by an FGM, such that its number of Gaussian components (classes) is determined by measuring the approximation error, and an
MRF model is used to quantify spatial pixel interactions, as well.

2.

Prior Work on Renal Function Assessment
Prior related work on renal function assessment using DW-MRI has been cov-

ered in details in Chapter I (Section I.E.4.c).
In total, several clinical studies have been conducted for the assessment of renal
function. However, they have some limitations. All the approaches employ manual delineation of the kidney using 2D ROIs, which is subjective and depends on user knowledge of
anatomy. In addition, these methods did not compensate for the kidney motion since they
did not account for the entire kidney. Furthermore, several of these studies performed only
statistical analysis to investigate the significant diﬀerence between pairs at certain b-values
and did not integrate all the analysis steps into a whole framework to build a fully automated CAD system. Finally, the studies mentioned above did not investigate the fusion of
ADCs at multiple low and high b-values.
As an initial idea to overcome these limitations, a recent study to distinguish between rejection and non-rejection renal transplants was made by [146]. Their study included 36 renal transplants of which 6 were non-rejection and 30 were rejection. After DW-MRI data motion correction using a 2D B-splines approach, they segmented the
largest coronal cross-section of the kidney using a fully automated level sets segmentation
approach. Then, they calculated the ADCs at diﬀerent b-values from the segmented coronal cross-section for each subject. By using a leave-one-subject-out scenario along with
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a KStar classifier, they got a 87% total classification accuracy. In addition, they depicted
color-maps from the calculated ADCs for the visualization purpose at diﬀerent b-values.
However, this study did not compensate for kidney motion as as it did not account for the
entire kidney volume. In addition, it did not investigate the fusion of multiple ADCs at
multiple low and high b-values for the entire kidney volume.
These initial promising diagnostic results obtained by [146] was the trigger to extend this work to overcome all of the aforementioned shortcomings. Therefore, a 4D (3D
+ b-value) fully automated CAD system has been developed [147, 148], shown in Figure 9, which is able to: (i) delineate the whole kidney and handle its motion; (ii) fuse the
ADC values calculated from the segmented DW-MRI data sets acquired at multiple low
and high b-values; (iii) describing kidney functionality with the CDFs of the ADCs; and
(iv) discriminating between kidney rejection and non-rejection with a deep neural network
learned by stacking layers of several auto-encoders with non-negativity constraint (NCAE).
Experimental results hold promise for the developed CAD system as a reliable non-invasive
diagnostic tool.

FIGURE 9: Proposed CAD system for detecting renal rejection from 4D DW-MRI.
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B. Methods
Given an input 4D (3D + b-value) DW-MRI, the proposed CAD system, shown in
Figure 9, performs the following steps: (i) segments kidneys from surrounding abdominal structures (Section II.B.1); (ii) estimates voxel-wise functional parameters (ADCs) to
form a 3D parametric map for detecting status of the transplanted kidney (Section II.B.2);
and (iii) classifies acute rejection or non-rejection transplant status in order to evaluate the
system as a diagnostic test (Section II.B.3).

1. 3D Kidney Segmentation
Since the segmentation is a key step in developing any CAD system, the presented
CAD starts with segmenting the kidney from the surrounding tissues using DW-MRI. However, accurate kidney segmentation is a challenging task for many reasons, including: kidney motion due to breathing and heart beating; kidney shape changes due to inter-patient
anatomical diﬀerences; low contrast between the kidney and other abdominal structures,
especially, at the higher gradient strengths and duration, or b-values (Figure 10); low SNR
and artifacts that complicate image alignment [149, 150]; and geometric distortions due to
long acquisition time [130].

(a)

(b)

(c)

FIGURE 10: Coronal cross-sections of raw DW-MRI samples showing (a) similar intensities of kidney and surrounding tissues (e.g., at b0 ), (b) inter-patient anatomical diﬀerences
(e.g., at b0 ) compared to the cross-section (a), and (c) image noise, especially, at higher
gradient strengths and duration (b-values) (e.g., at b1000 ).
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To overcome these challenges, the proposed segmentation technique [146, 151–153]
relies on multiple image features to accurately delineate the kidney and thus facilitates further analysis of transplant status. Basic notations and details of the proposed segmentation
approach are outlined below.
For describing these processing steps, let p = (x, y, z) denote a voxel at position
with discrete Cartesian coordinates (x, y, z) and let R = {(x, y, z) : 0 ≤ x ≤ X − 1; 0 ≤ y ≤
Y − 1; 0 ≤ z ≤ Z − 1} be a finite 3D arithmetic lattice of unit voxels, which has the size
of XYZ and supports both grayscale images and their parametric or region (segmentation)
maps. A grayscale image, g = {gp : p ∈ R; gp ∈ Q}, takes voxel values from a finite
set, Q = {0, 1, . . . , Q − 1}, of Q integer gray levels, i.e. g : R → Q. A region map,
m = {mp : p ∈ R; mp ∈ L}, takes voxel values from a binary set of region labels, L = {0, 1},
where 0 and 1 indicate background and object (kidney), respectively, i.e. m : R → L.
A 3D geometric, or level-set-based deformable boundary, is employed in the proposed CAD system for the DW-MRI kidney segmentation. Such a tool is common and
successful in a wide range of applications, including various medical imaging tasks, e.g.,
segmenting brain, prostate, liver, kidney, etc. [104]. Compared to alternative parametric
deformable boundaries, the geometric ones are more popular due to their simplicity, flexibility, and ability to handle complex geometries and topological changes independently of
surface parameterizations. Points of an object-background boundary at each time instant t
are specified implicitly as a zero-level set, Bt = {p : p ∈ R; Φ(p, t) = 0}, of arguments of
a specific higher-dimensional function Φ(p, t), being supported by the lattice R and often
called a signed distance map:




d(p, Bt ) if p is inside the boundary Bt ;







Φ(p, t) = 
0 if p is at the boundary Bt , and








 −d(p, Bt ) if p is outside the boundary Bt
Here, d(p, Bt ) = minb∈Bt d(p, b) denotes the distance from the point p to the boundary Bt ,
and d(p, b) is the Euclidean distance between the lattice points p and b, as illustrated in
Figure 11.
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FIGURE 11: 3D zero-level set of a function Φ(p = [x, y, z], t).
The function Φ(p, t) evolves in discrete time t = nτ with a fixed step, τ > 0, as [154]:
Φ(p, (n + 1)τ) = Φ(p, nτ) − τFn (p)|∇Φ(p, nτ)|

(1)

where n = 0, 1, 2, . . ., is the time index; ∇Φ(p, nτ) is the spatial gradient of Φ(p, nτ):
[
]
∂Φ(p, nτ) ∂Φ(p, nτ) ∂Φ(p, nτ)
∇Φ(p, nτ) =
,
,
;
∂x
∂y
∂z
|a| denotes the magnitude of the vector a, and Fn (p) is a speed function guiding the evolution of an initial boundary B0 , which was defined at the starting instant t = 0 (i.e. n = 0).
Most of the conventional speed functions quantify visual appearance diﬀerences
between the object and its background in terms of mean values and variances of image intensities, intensity edges or gradient vector flow, and similar regional signal characteristics.
Thus, their guidance may fail if images to be segmented are noisy and/or object-background
contrast is low. To accurately segment the kidneys from the noisy and low-contrast DWMRI, the developed guiding function accounts for not only regional kidney-background
appearance, but also for a kidney shape prior and spatial relationships of the goal region
map. To provide the voxel-wise guidance for the evolving boundary, all the employed
appearance and shape descriptors are combined into a joint MGRF model of a DW-MR
image, g, and its binary kidney-background region map, m. The model is specified by
a joint probability distribution P(g, m) = P(g|m)P(m), where P(g|m) and P(m) denote
a conditional probability distribution of images given a map and an unconditional distribution of region maps, respectively. The latter distribution is factored into two terms:
P(m) = Psp (m)PV (m), where Psp (m) denotes an appearance-based adaptive shape prior
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and PV (m) is a second-order Gibbs probability distribution with potentials V of multiple
nearest-neighbor pairwise dependencies, which specifies a simple spatially homogeneous
MGRF model of region maps. These components of the joint image-map model are outlined in the following Sections.
a. Appearance-Based Shape Prior: In addition to the distinct visual appearances, the well-known geometric shapes of medical structures can enhance the segmentation accuracy. To rely on this fact, an adaptive model of the expected kidney shape is used
to both handle kidney motions, e.g., due to breathing and/or heart beating, and account
for the kidney’s variability due to inter-patient anatomical diﬀerences. In addition, the
kidney DW-MR images are very noisy, especially at high b-values, and have low contrast
between the kidney tissue and other abdominal structures. The noise and inconsistencies
due to low-frequency non-uniformity, or heterogeneity of intensities, are suppressed in part
by preprocessing, namely, histogram equalization with nonparametric bias correction by
Tustison [155] shown in Figure 12.

(a)

(b)

FIGURE 12: Raw coronal DW-MRI cross-section before (a) and after (b) its preprocessing.
To build the shape prior, a shape database is created from a training set of manually
delineated kidney images from diﬀerent subjects by co-aligning these images using a 3D Bspline-based non-rigid transformation [156]. The alignment minimizes the sum of squared
voxel-wise intensity diﬀerences between the two kidney images, and kidney/background
labels of the co-aligned region maps are used to learn the shape prior. Figure 13 illustrates
the co-alignment of the training DW-MRI with respect to a single reference image.
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FIGURE 13: 3D co-alignment of training DW-MRI to a single reference: grayscale images
before (a) and after (b) their alignment and overlapped 3D binary volumes before (c) and
after (d) alignment, the reference image and targets being in yellow and red, respectively.
In the performed experiments, the shape database contained 53 data sets (b0 -scans)
manually segmented by an MRI expert and then co-aligned. Adapting the shape prior to
each input DW-MR image to be segmented is guided by visual appearance of the latter
image. The probabilistic shape prior is built as a spatially variant independent random field
∏
of region labels Psp (m) = p∈R Prp (mp ), where Prp (l) is the marginal empirical probability
∑
of the label l ∈ L in the voxel p; l∈L Prp (l) = 1. Algorithm summarizes estimating and
updating the appearance-guided shape prior for each test DW-MR image to be segmented
(the test images are first removed from the training set).
b. Second-Order MGRF Model of Region Maps: In order to increase the segmentation accuracy, 3D pairwise dependencies between the region labels are additionally
incorporated in the proposed model by using a popular Potts MGRF [157]. Here, it is a
spatially homogeneous binary field with the nearest 26-voxel neighborhoods and analytically estimated bi-valued Gibbs potentials depending only on whether or not the nearest
pairs of labels are equal. Let feq denote the empirical marginal probability of equal labels
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Algorithm 1 Creating / Updating the Shape Prior.
1 Preprocess the training DW-MR images by bias correction and histogram equalization.
2 Construct the shape database by applying the co-alignment by Glocker et al. [156] to
the preprocessed DW-MR Images.
3 Preprocess the DW-MR image for a test subject and co-align with the shape database.
4 For each voxel, p ∈ R, in the test DW-MR image, gtest , calculate its prior shape probabilities, Prp (l); l ∈ L, as follows:
A Use the co-aligning deformation field to relate the voxel p of the test image to the
shape database lattice.
B Construct a 3D window with initial size of N1 × N2 × N3 , centred at the related voxel
in the shape database lattice.
C Find within the window all the voxels with the corresponding intensity, gtest:p , in all
the training images.
D If necessary, increase the window size and repeat Steps 4B to 4D until a non-empty
set of such corresponding training intensities is found.
E Estimate label probabilities based on relative occurrences of each label in all the
training voxels found.
in the neighboring voxel pairs (p, p + δ) ∈ R2 ; δ ∈ N26 = {(±1, 0, 0), (0, ±1, 0), (0, 0, ±1),
(±1, ±1, 0), (±1, 0, ±1), (0, ±1, ±1), (±1, ±1, ±1)}. Given a region map m (e.g., after an initial rough segmentation), the maximum likelihood estimates of the potentials






 Veq if mp = mp+δ
V(mp , mp+δ ) = 
; p ∈ R; δ ∈ N26 ; Veq + Vne = 0




 Vne if mp , mp+δ
are analytically approximated [158] as follows: Veq = −Vne ≈ 2 feq (m) − 1. This approximation is used for computing the voxel-wise probabilities PrV:p (l) of each label; l ∈ L.
c. First-Order Kidney/Background Appearance Model: To accurately model
the DW-MRI appearance, the empirical marginal probability distribution of intensities is
approximated with a linear combination of discrete Gaussians (LCDG) [159]. The LCDG
with two positive dominant components (one each for the kidney and background) and
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multiple sign-alternate subordinate components allow for separating the mixed marginal
of the DW-MRI voxel-wise intensities into the two distinct LCDGs, each associated with
the kidney or background label. This LCDG model adapts the segmentation to changing
appearance, such as non-linear intensity variations caused by patient weight and the data
acquisition system, and it separates individual submodels of the kidney and background
intensities more accurately than a conventional mixture of only positive Gaussians. This
adaptation yields a better initial region map after the voxel-wise classification of only the
image intensities with no account for the kidney shape.
d. Appearance- and Shape-Guided Deformable Model: Adaptation to both the
kidney-background visual appearance, shape prior, and statistical spatial dependencies between kidney labels is one of the main advantages of the proposed segmentation framework.
Estimated directly from the input image and a given shape database, these properties guide
the evolving deformable boundary by defining, for each voxel p with intensity gp = q, the
speed function [104] of Equation (1), Fn (p) = κϑp , where κ is the mean contour curvature
and ϑp specifies the magnitude and direction of moving that voxel:






 − Prp (1) if Prp (1) > Prp (0) = 1 − Prp (1); i.e. Prp (1) > 0.5;
ϑp = 




 Prp (0) otherwise

(2)

Here, Prp (0) and Prp (1) are the voxel-wise background and kidney probabilities, respectively:
Prp (1) =

Ωkd:p
;
Ωkd:p +Ωbg:p

Prp (0) =

Ωbg:p
Ωkd:p +Ωbg:p

= 1 − Prp (1)

where the variables Ωkd:p and Ωbg:p for the kidney and background, respectively, depend on
the voxel-wise probabilities Pr(q|l); l ∈ L, for the LCDG submodels of the kidney (l = 1)
or background (l = 0) appearance and on the kidney label probability in the MGRF spatial
region map model, PrV:p (1), and in the adaptive shape prior, Prsp:p (1), respectively:
Ωkd:p = Pr(q|1) PrV:p (1) Prsp:p (1); Ωbg:p = Pr(q|0)(1 − PrV:p (1)(1 − Prsp:p (1))
Algorithm summarizes the basic steps of the 3D level-set-based kidney segmentation.
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Algorithm 2 DW-MRI Segmentation by Geometric Deformable Boundary
1 Update the shape prior probability using Step 4 of Algorithm .
2 Approximate the marginal of DW-MRI intensities with the LCDG [159] with two dominant components.
3 Form an initial region map, mini , using the estimated shape prior and LCDG submodes
of kidney and background appearances.
4 Estimate the Gibbs potentials for the spatial MGRF map model from mini .
5 Find the above speed function [104], Fn (p), using results of Steps 2 to 4.
6 Segment the input image, g, by evolving the level-set function, Φ(p, nτ), of Equation (1)
with the speed function found in Step 5.
2.

Estimating and Depicting Diﬀusion Parameters
After segmenting the kidneys, their discriminatory functional features are estimated

from the images and used to distinguish between rejection and non-rejection of kidney
transplants. In this chapter, the ADC defined by Le Bihan [160] is used as a transplant
status feature. This voxel-wise ADC is defined as:
(
)
gb:p
ln gb:p − ln g0:p
1
ADC =
ln
=
b0 − b
g0:p
b0 − b

(3)

where the segmented DW-MR images g0 and gb were acquired with the b0 and a given
diﬀerent b-value, respectively. To reduce the noise eﬀects on ADC estimation, the ADC at
each voxel p (3D location of the DW-MRI data) is calculated using a 3 × 3 × 3 cube around
p, and g0:p and gb:p are represented by the average signal intensity of that cube.
It is worth noting that conventional classification methods that deal directly with the
voxel-wise ADCs of the entire kidney volume as discriminative kidney features encounter
two diﬃculties: (i) varying input data size requires either data truncation for larger kidney
volumes or zero padding for smaller ones and (ii) large data volumes lead to considerable
time expenditures for training and classification.

In order to overcome the above chal-

lenges, the entire 3D ADC maps, collected for each subject at the 11 diﬀerent b-values,
is characterized by the CDFs of the ADCs, as shown in Figure 14. These descriptors are
independent of the initial data size and can be quantified in accordance with the actual ac-
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curacy (signal-to-noise ratio) of the ADCs. Preliminary experiments have shown that the
1%-accuracy of measuring the ADC to within a range between the maximum and minimum
ADCs for all the b-values and subjects is suﬃcient, as regarding the final classification accuracy. Comparing to the empirical probability distribution functions (PDFs) of the ADCs,
the CDFs allow better diﬀerentiation between the PDFs across the whole range of the ADC
values. The training CDFs are used for deep learning of a stacked NCAE (SNCAE) classifier detailed in Section II.B.3. Fixing the input data size to 11 for such CDFs helps to
overcome the above challenges for arbitrary sizes of the original ADCs and notably accelerates the classification. Also, the estimated 3D ADCs can be displayed as voxel-wise
parametric maps to be visually assessed by the radiologists.

FIGURE 14: Empirical ADC distributions and their CDFs for one subject at diﬀerent bvalues.

3.

Autoencoding and Deep Learning-Based Classifier
A rich variety of learnable classifiers with shallow structure [161–164] have been

used in the CAD systems for organ transplantation prediction using clinical and demographic data of patients, including (but not limited to) artificial neural networks (ANN),
support vector machines (SVMs), regression trees, random forests (RFs), decision trees
(DTs), k-nearest neighbor (kNN), etc. However, the aforementioned popular learnable
classifiers and predictors have some limitations [165, 166]: (i) some of them (e.g., RFs and
DTs) cannot deal with very large scale amounts of data, which are typical for DW-MRI;
(ii) some of them (e.g., SVMs) depend mainly on the selection of the kernel function and
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its parameters; (iii) many classifiers (e.g., SVMs, RFs) are of high algorithmic complexity
and require extensive memory.
Recent advances in deep learning of the ANNs [167] allow for overcoming these
drawbacks of the classical shallow models: (i) by automated dimensionality reduction of
large scale data [168]; (ii) and automatic extraction of more discriminatory features between classes through hierarchical feature extraction. In this case, the high level (global)
features are derived from the low level (local) features for model training [168–171];
(iii) and flexibility compared to the classical shallow models, i.e. a classifier (e.g., a
softmax-based or SVM-based) can be built on the extracted features from the deep learning
ANN [168, 172].
Due to the aforementioned advantages, the proposed fully automated CAD system utilizes deep learning and auto-encoders with non-negativity constraint (NCAE) as a
core ANN architecture for pre-training and classification to distinguish between the nonrejection and acute rejection of kidney transplants. In particular, the presented CAD system
employs a deep neural network with a stack of auto-encoders (AE) before the output layer
that computes a softmax regression, generalizing the common logistic regression to more
than two classes. Each AE compresses its input data to capture the most prominent variations and is built separately by greedy unsupervised pre-training [173]. The softmax output
layer facilitates the subsequent supervised back-propagation-based fine tuning of the entire
classifier by minimizing the total loss (negative log-likelihood) for a given training labeled
data. Using the AEs with a non-negativity constraint (NCAE) [174] yields both more reasonable data codes (features) during its unsupervised pre-training and better classification
performance after the supervised refinement.
Let W = {Wej , Wdi : j = 1, . . . , s; i = 1, . . . , n} denote a set of column vectors of
weights for encoding (e) and decoding (d) layers of a single AE in Figure 15. Let T denote
vector transposition. The AE converts an n-dimensional column vector u = [u1 , . . . , un ]T
of input signals into an s-dimensional column vector h = [h1 , . . . , h s ]T of hidden codes
(features, or activations), such that s ≪ n, by a uniform nonlinear transformation of s
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weighted linear combinations of signals:
hj = σ

((

)T
Wej

 n

∑ e 
u ≡ σ  w j:i ui 
)

i=1

FIGURE 15: Block-diagram of an NCAE (a) and an SNCAE (b) classifier.
where σ(. . .) is a certain sigmoid, i.e. a diﬀerentiable monotone scalar function
with values in the range [0, 1]. Unsupervised pre-training of the AE minimizes total deviations between each given training input vector uk ; k = 1, . . . , K, and the same-dimensional
vector, b
uW:k reconstructed from its code, or activation vector, hk (Figure 15(a)). The total
reconstruction error of applying such AE to compress and decompress the K training input
vectors integrates the ℓ2 -norms of the deviations:
K
1 ∑
JAE (W) =
∥b
uW:k − uk ∥2
2K k=1

(4)

To reduce the number of negative weights and enforce sparsity of the NCAE, the reconstruction error of Equation (4) is appended, respectively, with quadratic negative weight
penalties, f (wi ) = (min{0, wi })2 ; i = 1, . . . , n, and Kullback-Leibler (KL) divergence,
JKL (hWe ; γ), of activations, hWe , obtained with the encoding weights We for the training
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data, from a fixed small positive average value, γ, near 0:
s ∑
n
∑
JNCAE (W) = JAE (W) + α
f (w j:i ) + βJKL (hWe ; γ)

(5)

j=1 i=1

Here, the factors α ≥ 0 and β ≥ 0 specify relative contributions of the non-negativity and
sparsity constraints to the overall loss, JNCAE (W), and
(
)
(
)
s
∑
hWe : j
1 − hWe : j
JKL (hWe , γ) =
hWe : j log
+ (1 − hWe : j ) log
γ
1−γ
j=1

(6)

The classifier is built by stacking the NCAE layers with an output softmax layer,
as shown in Figure 15(b). Each NCAE is pre-trained separately in the unsupervised mode
by using the activation vector of a lower layer as the input to the upper layer. Here, the
initial input data consisted of the 11 CDFs, each of size 100, i.e. n = 1100. In other words,
for quantizing the ADCs, the range between the minimum and maximum ADCs for all the
input data sets (i.e. all the sets for 11 b-values and 53 subjects) was divided into 100 steps
to keep the chosen 1%-accuracy of initial ADC measurements. The PDFs and then CDFs
of the ADCs were built for these quantized values. The bottom NCAE compresses the
input vector to s1 first-level activators, compressed by the next NCAE to s2 second-level
activators, which are reduced in turn by the output softmax layer to s◦ values. The number
of the NCAE layers and successive data compression ratios for each layer were chosen
empirically, on the basis of comparative experiments.
Separate pre-training of the first and second layers by minimizing the loss of Equation (5) reduces the total reconstruction error, as well as increases sparsity of the extracted
activations and numbers of the non-negative weights. The activations of the second NCAE
layer, h[2] = σ(We[2] T h[1] ), are inputs of the softmax classification layer, as sketched in Figure 15(b) to compute a plausibility of a decision in favor of each particular output class,
c = 1, 2:
p(c; W◦:c ) =

2
∑
exp(WT◦:c h[2] )
;
c
=
1,
2;
p(c; W◦:c ; h[2] ) = 1.
exp(WT◦:1 h[2] ) + exp(WT◦:2 h[2] )
c=1

Its separate pre-training minimizes the total negative log-likelihood J◦ (W◦ ) of the known
training classes, appended with the negative weight penalties:
s2
K
2 ∑
∑
1∑
o
J◦ (W ) = −
log p(ck ; W◦:c ) + α
w◦:c: j
K k=1
c=1 j=1
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(7)

Finally, the entire stacked NCAE classifier (SNCAE) is fine-tuned on the labeled
training data by the conventional error back-propagation through the network and penalizing only the negative weights of the softmax layer. In the performed experiments, the
network was trained and tested based on a leave-one-out scenario, so that the 53 (by the
number of subjects) test accuracies were averaged to estimate the overall accuracy of the
classifier. These experiments were conducted for diﬀerent structures and parameters of the
classifier. At this point, the two-layer SNCAE classifier with the following parameters:
s1 = 50, s2 = 5, s◦ = 2, α = 3 ∗ 10−5 , β = 3, and γ = 0.1, is considered to give the best
accuracy and was accepted as the final choice. Algorithm summarizes classification of
kidney transplant status and generation of color ADC maps.
Algorithm 3 Kidney Transplant Status Classification and ADC Color Mapping
1 Calculate, using Equation (3), the ADCs at diﬀerent b-values for the entire transplanted
kidney of each subject.
2 Classification:
A Construct the CDFs of the calculated ADCs over the entire kidney volume at diﬀerent
b-values.
B Use a SNCAE-based deep ANN classifier trained by unsupervised pre-training and
supervised fine tuning together with a leave-one-subject-out approach to discriminate
rejection from non-rejection status and get the final diagnosis.
3 Generation of color ADC maps: Generate voxel-wise color-coded maps of the ADCs
calculated in Step 1 to demonstrate visually perceived diﬀerences between the rejection
and non-rejection states of kidney transplants at diﬀerent b-values.
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C. Experimental Results

1.

DW-MRI Data Collection
The proposed CAD system has been tested on DW-MRI data that has been collected

from 53 subjects (44 men and 9 women with ages between 12 and 54 years old, having a
mean age of 26 ± 10 years). Both the rejection (37 subjects) and non-rejection (16 subjects)
groups, as a part of routine medical care after transplantation, were assessed with serum creatinine laboratory values. The patient who subsequently underwent an ultrasound-guided
needle biopsy was examined, based on their clinical indication, as the gold standard. The
DW-MR images were acquired before any biopsy procedure using a 1.5 T scanner ( SIGNA
Horizon, General Electric Medical Systems, Milwaukee, WI). Coronal DW-MR images
have been obtained by using a body coil and a gradient multi-shot spin-echo echo-planar
sequence ( TR/TE, 8000/61.2; bandwidth, 142 kHz; matrix, 1.25 × 1.25 mm2 ; section thickness, 4 mm; intersection gap, 0 mm; FOV, 32 cm; signals acquired, 7; water signals acquired
at diﬀerent b-values of (b0 , b50 , b100 , b200 , b300 , b400 , b500 , b600 , b700 , b800 , b900 , and b1000 )
s/mm2 ). Approximately 50 sections have been obtained in 60 - 120 s to cover the whole
kidney.

2.

Segmentation Results
Since the segmentation is an important step in developing any CAD system to as-

sess renal function, the performance of the proposed segmentation was tested first on the
collected DW-MRI data. Figure 16 shows some segmentation results for diﬀerent kidney
cross-sections (coronal, axial, and sagittal) for three subjects at b0 . The segmentation accuracy was evaluated by two volumetric metrics, namely, the Dice similarity coeﬃcient
(DSC) [175, 176] and absolute kidney volume diﬀerence (AKVD) and one distance-based
metric – the 95-percentile modified Hausdorﬀ distance (MHD) [177], which characterize the spatial overlap and distribution of the surface to surface distances between the
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segmented and ground truth kidneys, respectively. The ground truth kidney maps were
manually outlined by an MRI expert. For completeness, these metrics are detailed in Appendix .A.

FIGURE 16: The proposed model segmentation (red) with respect to the expert’s manual ground truth (green): coronal (left column), axial (middle column), and sagittal (right
column) cross sections for three diﬀerent subjects, S1 , S2 , and S3 .
As shown in Table 1, high accuracy of the developed segmentation method is confirmed by means of the DSC, MHD, and AKVD statistics for all the test data sets. Moreover, the accuracy of the proposed segmentation technique was compared against three
other methods: the level-sets approach by Chan and Vese [2] (CV), the level-sets guided by
image intensity only, and the level-sets guided by combined intensity and spatial features
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TABLE 1: Segmentation accuracy of the proposed segmentation method using DSC,
MHD(mm), and AKVD(%). All metrics are represented as minimum (Min), maximum
(Max), and mean± standard deviation (SD).
Evaluation Metrics
DSC

MHD (mm)

AVKD (%)

Min

0.85

4.00

8.00

Max

0.96

20.00

25.00

0.92 ± 0.02

6.20 ± 2.00

15.00 ± 3.00

mean±SD

TABLE 2: Segmentation accuracy of the proposed segmentation technique against three
other level-sets methods using DSC, MHD(mm), and AKVD(%). All metrics are represented as mean± standard deviation (SD).
Evaluation Metrics
DSC

MHD

AVKD

Mean±SD P-value Mean±SD P-value
Proposed 0.92±0.02%

——

6.20±2.00

——

Mean±SD

P-value

15.00±3.00%

——

CV [2]

0.69±0.11% < 0.0001 75.97±11.96 < 0.0001 46.05±13.18% < 0.0001

I Only

0.54±0.07% < 0.0001 29.14±5.34 < 0.0001 62.33±7.12% < 0.0001

I+S

0.63±0.05% < 0.0001 22.79±7.36 < 0.0001 53.82±5.35% < 0.0001

using the same aforementioned segmentation evaluation metrics. Table 2 shows that the
advantage of the developed segmentation approach is statistically significant with respect
to the other methods, evidenced by the P-values less than 0.05, which confirms the high
accuracy of the proposed segmentation techniques.
Figure 17 shows 3D results of the proposed segmentation method for three subjects
along with their evaluation metrics. In particular, the developed segmentation technique
proved its ability to precisely segment the kidney at higher bi values.
Figure 18 shows more coronal cross-sectional segmentation results for three diﬀerent subjects at b0 and higher bi values (b500 and b1000 ) which in turn emphasize the high
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FIGURE 17: The proposed 3D segmentation (red) with respect to the expert’s manual
ground truth (green) for three subjects with the associated DSC, MHD, and AKVD accuracy scores.
accuracy and robustness to noise of the proposed kidney segmentation technique.

(b0 )

(b500 )

(b1000 )
FIGURE 18: Four more coronal cross-sections (columns) for the proposed kidney segmentation from DW-MRI acquired at diﬀerent b-values s/mm2 .

52

(Proposed)

(CV)

(I)

(I + S )
(a)

(b)

(c)

FIGURE 19: Comparative cross-sectional segmentation results for our approach, the traditional CV [2] level-set, the level-set guided by intensity alone, and intensity and spatial,
respectively, in rows for three diﬀerent types of cross sections (coronal cross section in the
first column, axial cross section in the second column, and sagittal cross section in the third
column) for one subject at b0 s/mm2 . The model segmentation is shown in red with respect
to the manual ground truth (green) from an expert.
The comparative accuracy of the proposed approach versus the CV method on representative data at diﬀerent types of kidney cross sections (i.e., axial, sagittal, and coronal)
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(b300)

(b500)

(b700)

(b1000)
(a)

(b)

(c)

(d)

FIGURE 20: A sample coronal cross-sectional kidney segmentation for DW-MRI data
acquired at b300 s/mm2 (first row), b500 s/mm2 (second row), b700 s/mm2 (third row), and
b1000 s/mm2 (fourth row) for (a) the proposed approach; (b) the CV [2] approach; (c) the
level-set guided by intensity only; and (d) intensity and spatial.
for one selected subject acquired at b0 is shown in Figure 19.
In order to assess the renal function using DW-MRI-based CAD systems, which in
turn has gained increased attention in recent years [178], the estimation of diﬀusion parameters (e.g., ADC) requires the accurate segmentation of the kidney on DW-MRI data
acquired at both higher and lower b-values. However, the accurate segmentation of kidney
volumes at higher b-values is a challenge compared with those at lower b-values because
of the decreased contrast between the object and the background. In spite of the aforementioned challenge, the proposed segmentation technique extracts accurately the kidney from
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diﬀusion data at higher b-values compared to the other three aforementioned methods as
shown in Figure 20. In contrast to the existing DW-MRI approaches, the integration of
the 3D appearance, shape, and spatial features increases the robustness of the proposed approach to overcome large image noise at higher b-values. Figure 20 demonstrates a sample
coronal cross section segmentation for four subjects at b-values of 300, 500, 700 and 1000
s/mm2 for the developed approach and the three other approaches used before. As shown
in this figure, the proposed approach produces precise segmentation of the kidney at higher
b-values compared with the other methods with respect to the ground truth segmentation.

3.

Diagnostics Results
Following kidney segmentation, the developed CAD system classifies the transplant

status with the SNCAE-based classifier and CDFs as discriminatory features. A leave-onesubject-out classification scenario applied to distinguish between the rejection and nonrejection cases from the CDFs of the ADCs for diﬀerent b-values has correctly classified
98% of the cases, namely, 36 out of the 37 rejected and 16 out of the 16 non-rejected kidney
transplants.
It is worth mentioning that fusing all the CDFs of the ADCs calculated at the 11
diﬀerent b-values, totally improves the final diagnostic accuracy, as shown in Table 3, and
helps to overcome the challenge of possible artifacts due to chemical shifts, which could
occur at one or two b-values, if the artifacts exist.
TABLE 3: Diagnostic accuracy based on the input CDF of the ADC for individual b-values
and the fused CDFs of all b-values.
Classification Accuracy
b50

b100

b200

b300

b400

b500

b600

b700

b800

b900 b1000 Fused b-values

75% 85% 75% 81% 70% 77% 62% 60% 64% 62% 74%

98%

In order to evaluate the eﬀect of the CDFs encoding step (∆) on the overall accuracy,
the CDFs of the 3D ADCs were constructed using two diﬀerent ∆i (∆ = 0.02 and 0.04).
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Then, the SNCAE classifier was applied on the constructed CDFs and the results are shown
in Table 4. As demonstrated in Table 4, the overall accuracy, sensitivity, and specificity,
have been greatly reduced. This can be explained in part by the fact that increasing the value
of ∆ results in losing important data information, thus making the data not well-presented,
which in turn aﬀects the classifier performance.
TABLE 4: Diagnostic accuracy, sensitivity, and specificity for the developed CAD system
with the SNCAE classifier using diﬀerent CDF encoding steps (∆i ).
Quality of classification
∆i :

Accuracy

Sensitivity

Specificity

∆1 = 0.01

98%

97%

100%

∆2 = 0.02

85%

86%

81%

∆3 = 0.04

83%

84%

81%

Furthermore, the eﬀect of changing the SNCAE structure on the overall accuracy
has been investigated by using diﬀerent SNCAE layouts (diﬀerent number of hidden layers
(l) and hidden nodes at each layer (sl )). From the results in Table 5, the network structure
with two hidden layers s1 = 50 and s2 = 5, demonstrated the highest accuracy.
TABLE 5: Diagnostic accuracy, sensitivity, and specificity for the developed CAD system
with the SNCAE classifier using diﬀerent structures, i.e., diﬀerent number of hidden layers
(l) and hidden nodes at each layer (sl ), using the same input size of 1100 (11 CDFs each of
100 region), α = 3 ∗ 10−5 , β = 3, and γ = 0.1.
Quality of classification
SNCAE Structure:

Accuracy

Sensitivity

Specificity

s1 = 5

85%

84%

88%

s1 = 25

60%

68%

44%

s1 = 50

68%

70%

63%

s1 = 50 and s2 = 5

98%

97%

100%

s1 = 50, s2 = 25, and s3 = 5

77%

92%

44%
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In addition to the leave-one-subject-out approach, a four-fold cross-validation test
has been performed where 75% of the data was used for training and the other 25% for
testing, to further validate and justify the performance of the SNCAE classifier. As documented in Table 6, the diagnostic accuracy of the combined SNCAE classification system
is almost independent of the choice of the training and testing data sets. The four-fold
cross-validation experiment demonstrated an average accuracy of 96%.
TABLE 6: Sensitivity to a training set based on a four-fold cross-validation scenario.
Cross-validating SNCAE classifier
Testing group (25%)
Correct/All
Accuracy

1

2

3

4

12/13

12/13

13/13

14/14

92%

92%

100%

100%

Average Accuracy

96%

To evaluate capabilities of the SNCAE classifier, it has been compared with seven
well-known learnable classifiers from the Weka collection [1]: K*, IBK, Naive Bayes tree
(NBT), Multi-class classifier (MCC), Decorate, Random tree (RT), and Random forest
(RF). Table 7 presents their and the presented diagnostic accuracy in terms of the numbers
of correctly classified rejection and non-rejection cases with respect to the overall numbers
of subjects, sensitivity, and specificity. The SNCAE classifier demonstrated the best total
diagnostic accuracy of 98% with 100 % specificity, or 16 correctly classified non-rejected
transplants out of the 16 subjects, and 97% sensitivity, or 36 correctly classified rejected
transplants out of the 37 subjects.
In addition, the receiver operating characteristics (ROC) (see Appendix .A) for the
developed CAD system with SNCAE and the chosen seven Weka classifiers in Figure 21
have been constructed to test the performance. As shown in Figure 21, the area under
the curve (AUC) is the highest for the SNCAE classifier and approaches the top-most unit
value (see Table 7). These initial diagnostic results confirm that the proposed CAD system
holds promise as a reliable non-invasive diagnostic tool.
Together with the automated classification, the proposed CAD system also provides
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TABLE 7: Diagnostic accuracy in terms of correctly classified vs. true non-rejection (NR)
and rejection (R) cases, sensitivity, specificity, and AUC for the proposed CAD system with
the SNCAE classifier and seven classifiers from the Weka collection [1].
Classification Accuracy
NR

R

Accuracy

Sensitivity

Specificity

AUC

K*

12/16

30/37

79%

81%

75%

0.82

IBK

15/16

36/37

96%

97%

94%

0.96

NBT

11/16

30/37

77%

81%

69%

0.79

MCC

15/16

34/37

92%

92%

94%

0.94

Decorate

8/16

34/37

79%

92%

50%

0.80

RT

10/16

29/37

74%

78%

63%

0.74

RF

9/16

35/37

83%

95%

56%

0.82

SNCAE

16/16

36/37

98%

97%

100%

0.97

FIGURE 21: ROC curves and their AUC for SNCAE and Weka classifiers [1].
voxel-wise parametric ADC maps, which can help in local visual assessment of the transplanted kidney. The color-coded ADC map, which depicts the estimated voxel-wise ADCs
of Equation (3), is more informative than the ADC CDFs collected over the entire kidney
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and thus hides local peculiarities of spatial behavior of the ADCs. Examples of the ADC
maps for two non-rejection and two acute rejection cases for the DW-MRI at the diﬀerent
b-values in Figure 22 demonstrate some expected relations between the local ADCs, which
could be helpful for assessing the transplant and detecting its non-rejection or rejection
status.

FIGURE 22: Pixel-wise parametric maps for DW-MRI at diﬀerent b-values (b50 to b1000 )
s/mm2 and their average value for two non-rejection (S 1 , S 2 ) and two rejection (S 3 , S 4 )
subjects.

D. Chapter Summary
The developed CAD system for early detection of renal transplant rejection from 4D
DW-MRI data combines existing and new techniques for non-rigid image alignment, kidney segmentation with a deformable boundary, estimation of spatial diﬀusion parameters
(ADCs), and an SNCAE classification of the transplanted kidney status using CDFs of the
ADCs as integral status descriptions. In a test on a biopsy-proven cohort of 53 participants,
the devloped system showed an overall accuracy of 98% in detecting rejected and nonrejected kidney transplants. These experimental results make the proposed non-invasive
framework a reliable early renal diagnostic tool. In the future, the test sets of both non-
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rejection and rejection kidney transplants will be increased in order to further validate the
accuracy and robustness of the proposed framework in both segmentation of the DW-MRI
and diagnosis. Also, new kidney transplant data sets, which are acquired at lower b-values,
will be used to explore the ability of the proposed framework to determine the type of kidney transplant rejection, such as anti-body mediated rejection, T-cell or cellular rejection,
or other causes of acute kidney dysfunction such as drug toxicity and viral infection.
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CHAPTER III
CONCLUSIONS AND FUTURE WORK

This thesis has presented a novel computer-aided diagnostic (CAD) system coupled
with diﬀusion-weighted magnetic resonance imaging (DW-MRI) for the early detection of
acute renal rejection after transplantation. Fortunately, the presented work in this thesis
confirms the power of DW-MRI as an emerging imaging modality, with great thanks to
its ability to provide both anatomical and functional information about both original and
transplanted kidneys without exposing patients to any radiation, and with no need for contrast agents administration like the DCE-MRI. Therefore, a fully automated CAD system
for early detection of acute renal transplant rejection was coupled with DW-MRI utilizing
the aforementioned merits of DW-MRI. The developed CAD system for early detection of
renal transplant rejection from 4D DW-MRI data combines existing and new techniques
for non-rigid image alignment, kidney segmentation with a deformable boundary, estimation of functional diﬀusion parameters, called apparent diﬀusion coeﬃcients (ADCs), and a
stacked nonnegativity constrained autoencoder (SNCAE) classification of the transplanted
kidney status using cumulative distribution functions (CDFs) of the ADCs as integral status
descriptions.

A.

Summary of Contributions

The main findings and contributions of this thesis can be summarized as follows:
• A new fully-automated computer-aided diagnostic (CAD) system using 4D (3D +
b-value) diﬀusion-weighted magnetic resonance imaging (DW-MRI) for early determination of the transplanted kidney status as nonrejection or rejection.
• Fusion of the apparent diﬀusion coeﬃcients (ADCs) at multiple low and high gra-
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dient field strengths and duration (b-values) estimated from the segmented kidneys
(subjects) using the proposed segmentation approach. The segmentation is done after
a non-rigid image alignment for all subjects to a single reference subject.
• Exploring new discriminatory features to distinguish between nonrejected and rejected kidney transplants. These features are based on constructing cumulative distribution functions (CDFs) from the estimated ADCs at diﬀerent b-values form b0 to
b1000 s/mm2 for all segmented kidneys. It is worth mentioning that, the use of those
CDFs instead of the voxel-wise ADCs of the entire kidney volume helps in making the data well-presented and mainly solves three important challenges of diﬀerent
kidney volumes: (i) loss of important information by data truncation for large kidney
volumes; (ii) addition of nonexisting information by zero padding for small kidney
volumes; and (iii) considerable time expenditures for training and classification for
large kidney volumes.
• The use of stacked autoencoders with nonnegativity constraint (SNCAE) classifier
for the purpose of discriminating nonrejected from rejected transplanted kidneys. After fusing all the constructed CDFs at diﬀerent b-values for each subject, the SNCAE
is trained and tested with these fused CDFs for all subjects by using a leave-onesubject-out approach and a four-fold cross-validation scenario as well.

B. Future Avenues
Several future trends that can be deeply investigated include but are not limited to
the following avenues:
• Exploiting a new segmentation technique using a nonnegative matrix factorization
(NMF)-guided active contour model to enhance and improve the segmentation accuracy. Some initial promising segmentation results have been obtained [179]
• After diﬀerentiating rejection from nonrejection kidney transplants, the next step is
to obtain new DW-MRI data volumes at lower b-values and to investigate in-depth
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the ability of the proposed CAD system to diﬀerentiate between diﬀerent types of
rejection (e.g., T-cell mediated rejection, anti-body mediated rejection, immunosuppressive toxicity, and viral infection) as it is a very important step for therapeutic
purposes and for the determination of the appropriate treatment. Preliminary results
for diﬀerentiating between diﬀerent types of rejection are preferably found in [180]
• A new trend to be investigated is considering the fusion of multiple discriminating
features extracted from images (e.g., CDFs of ADCs) with clinical data such as creatinine clearance (CrCl) and serum plasma creatinine (SPCR) to enhance and support
the classification process with the clinical data as well, which in turn can provide a
meaningful coupling of information provided by imaging and clinical information.
Please see [181] for some initial results.
• Constructing a new two-cascaded stages CAD system utilizing the fusion of imagebased with clinical-based biomarkers with the ability to diﬀerentiate nonrejection
kidney transplants from transplanted kidneys with abnormalities (graft dysfunction)
in the first stage. Then, classifying these abnormal kidneys as kidneys with early
rejection and kidneys with other diseases (e.g., tubular inflammation, acute tubular
injury, graft amyloidosis, etc.). Preliminary results of the suggested idea can be found
in [181].
• Conducting a new study to investigate the ability of the proposed segmentation approach to extract the prostate from the surrounding tissues using DCE-MRI and DWMRI [182–195].
• Extending the developed segmentation approach to segment the heart left/right ventricle wall by using contrast enhanced cardiac magnetic resonance images [196–218].
• Exploring the ability of the proposed CAD system to detect other organ diseases like
lung cancer using contrast enhanced computed tomography (CECT) images [219–
267].
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• Investigating the capability of the developed CAD system to detect brain disorders
and abnormalities (e.g., dyslexia, autism, etc.) [159, 268–311].
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[117] K. Hueper, A. A. Khalifa, J. H. Bräsen, V. Chieu, V. Dai, M. Gutberlet, S. Wintterle,
F. Lehner, N. Richter, M. Peperhove, et al. Diﬀusion-weighted imaging and diﬀusion
tensor imaging detect delayed graft function and correlate with allograft fibrosis in
patients early after kidney transplantation. Journal of Magnetic Resonance Imaging,
2016.
[118] J. Xu, W. Xiao, L. Zhang, and M. Zhang. [value of diﬀusion-weighted MR imaging in diagnosis of acute rejection after renal transplantation]. Journal of Zhejiang
University. Medical Sciences, 39(2):163–167, 2010.
[119] S. Palmucci, L. Mauro, P. Veroux, G. Failla, P. Milone, G. Ettorre, N. Sinagra,
G. Giuﬀrida, D. Zerbo, and M. Veroux. Magnetic resonance with diﬀusion-weighted
imaging in the evaluation of transplanted kidneys: Preliminary findings. In Transplantation Proceedings, volume 43, pages 960–966. Elsevier, 2011.
[120] S. Palmucci, L. Mauro, G. Failla, P. Foti, P. Milone, N. Sinagra, D. Zerbo, P. Veroux,
G. Ettorre, and M. Veroux. Magnetic resonance with diﬀusion-weighted imaging in
the evaluation of transplanted kidneys: Updating results in 35 patients. In Transplantation Proceedings, volume 44, pages 1884–1888. Elsevier, 2012.
[121] P. Vermathen, T. Binser, C. Boesch, U. Eisenberger, and H. C. Thoeny. Threeyear follow-up of human transplanted kidneys by diﬀusion-weighted MRI and blood
oxygenation level-dependent imaging. Journal of Magnetic Resonance Imaging,
35(5):1133–1138, 2012.
[122] K. Wypych-Klunder, A. Adamowicz, A. Lemanowicz, W. Szczȩsny, Z. Włodarczyk,
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APPENDIX

A.

Evaluating Segmentation Accuracy

Performance of the proposed segmentation was evaluated by using three accuracy
metrics: (i) the Dice similarity coeﬃcient (DSC) [175, 176], (ii) the 95-percentile modified
Hausdorﬀ distance (MHD) [177], and (iii) the absolute kidney volume diﬀerence (AKVD),
which are detailed below.
The Dice similarity coeﬃcient (DSC), shown in Figure 23, measures the relative
overlap between the segmented and ground truth kidney in terms of true positive (T P),
false positive (FP), and false negative (FN) absolute volumes of the correctly segmented
kidney voxels, background voxels segmented as the kidney, and kidney voxels segmented
as the background, respectively:
DS C =

2T P
; 0 ≤ DS C ≤ 1
2T P + FP + FN

(A-1)

FIGURE 23: 2D illustration of segmentation errors calculation between the segmented and
ground truth objects for the DSC determination.
The higher the DSC, the better the segmentation (zero and unit DSC indicate no
overlap and ideal overlap, respectively).
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The modified Hausdorﬀ distance (MHD), shown in Figure 24, measures the largest
surface-to-surface distance between the segmented and ground truth kidney borders. The
conventional asymmetric Hausdorﬀ distance (HD) [177] from a set of points A1 to a set of
points A2 is defined as the maximum Euclidean distance d(p1 , p2 ) between the points p1 of
A1 to their nearest points p2 in A2 :
}
HD(A1 , A2 ) = max min {d(p1 , p2 )}
{

p1 ∈A1

p2 ∈A2

(A-2)

Generally HD(A1 , A2 ) , HD(A2 , A1 ). Therefore, the symmetric bidirectional HD (BHD)
is defined as BHD(A1 , A2 ) = max{HD(A1 , A2 ), HD(A2 , A1 )}.

FIGURE 24: 2D schematic illustration for the HD calculation.
To escape possible outliers, aﬀecting both the HD and BHD, and measure more robustly the segmentation accuracy, the 95-percentile BHD, called the modified HD (MHD),
is used in this paper. In this case, the maximum distance in Equation (A-2) is replaced with
the 95-percentile of all the point-to-point distances d(p1 , p2 ).
The absolute kidney volume diﬀerence (AKVD), shown in Figure 25, measures the
relative volumetric diﬀerence between the segmented and ground truth kidney (their absolute volumes are equal to Vsegm = T P + FN and Vtrue = T P + FP, respectively):
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AKV D = 100

|Vsegm | − |Vtrue |
%
|Vtrue |

(A-3)

FIGURE 25: 3D schematic illustration for the AKVD estimation.
The receiver operating characteristic (ROC) [312] is an alternative metric to further test the classification accuracy and robustness of a CAD system compared to other
classifiers. The sensitivity and discriminability of a classifier is evaluated in a Cartesian
plane of relative true positive and false positive rates by its ROC curve for diﬀerent operating points, e.g., various decision thresholds. The area under the ROC curve (AUC)
characterizes the classification accuracy, namely, the probability of the correct renal transplant status detection for a randomly chosen pair of patients.
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B.

List of Abbreviations

TABLE 8: List of abbreviations that have been used in this thesis.
Abbreviation

Full Definition

CKD

Chronic Kidney Disease

NKF

National Kidney Foundation

GFR

Glomerular Filtration Rate

MRI

Magnetic Resonance Imaging

UNOS

United Network of Organ Sharing

AKR

Acute Kidney Rejection

ATN

Acute Tubular Necrosis

ITox

Immunosuppressive Toxicity

VI

Viral Infection

CT

Computed Tomography

US

Ultrasound

PI

Pulsatility Index

RI

Resistance Index

PD

Power Doppler

CD

Color Doppler

CE

Contrast Enhanced

IGF

Immediate Graft Function

SGF

Slow Graft Function

DGF

Delayed Graft Function

DKT

Dual Kidney Transplantation

SKT

Single Kidney Transplantation

AR

Acute Rejection

ROI

Regions of Interest

continued on the next page . . .
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Table 8 – continued from the previous page
Abbreviation

Full Definition

CP

Cortical perfusion

SCr

Serum Creatinine

USCM

Ultrasound Contrast Media

CEUS

Contrast Enhanced Ultrasound

CES

Contrast Enhanced Sonography

CDUS

Contrast Enhanced UltraSonography

RBF

Renal Blood Flow

AKI

Acute Kidney Injury

TIC

Time-Intensity Curves

ATPI

Arrival Time Parametric Imaging

IT

Inflow Time

RisT

Rising Time

AT

Arrival Time

TTP

Time to Peak

DCE-MRI

Dynamic Contrast Enhanced MRI

RBF

Renal Plasma Flow

NGF

Normalized Gradient Field

LS-SVM

Least Square Support Vector Machine

MTT

Mean Transit Time

BOLD-MRI

Blood Oxygen Level Dependant MRI

R2*

Apparent Relaxation Rate

CR2*

Cortical R2*

MR2*

Medullary R2*

MCR2*

Medullary to Cortical R2*

SNR

Signal-to-Noise Ratio

continued on the next page . . .
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Table 8 – continued from the previous page
Abbreviation

Full Definition

DW-MRI

Diﬀusion-Weighted MRI

ADC

Apparent Diﬀusion Coeﬃcient

CRCL

Creatinine Clearance

IniGF

Initial Graft Function

ARTR

Acute Renal Transplant Rejection

TD

True Diﬀusion

ACR

Acute Cellular Rejection

CAD

Computer-Aided Diagnostic

SPCR

Serum Plasma Creatinine

CDF

Cumulative Distribution Function

NCAE

Non-negativity Constrained Autoencoder

NMF

Nonnegative Matrix Factorization

SVM

Support Vector Machine

RVM

Relevant Vector Machine

MRF

Markov Random Field

MHD

Modified Housdorﬀ Distance

MGRF

Markov-Gibbs random field

FGM

Finite Gaussian Mixture

LCDG

Linear Combination of Discrete Gaussians

PDF

Probability Distribution Function

SNCAE

Stacked Non-negativity Constrained Autoencoder

ANN

Artificial Neural Network

RF

Random Forest

DT

Decision Tree

kNN

K-nearest Neighbor

continued on the next page . . .

98

Table 8 – continued from the previous page
Abbreviation

Full Definition

AE

Auto-encoder

KL

Kullback-Leibler

DSC

Dice Similarity Coeﬃcient

AKVD

Absolute Kidney Volume Diﬀerence

BHD

Bidirectional Hausdorﬀ Distance

NBT

Naive Bayes Tree

MCC

Multi-class Classifier

RT

Random Tree

ROC

Receiver Operating Characteristic

AUC

Area Under the Curve

99

CURRICULUM VITAE

Mohamed Nazih Shehata
Paul C. Lutz Hall, Room # 309
BioImaging Laboratory
Department of Bioengineering
University of Louisville, Louisville, KY, USA
University E-mail:mnsheh01@louisville.edu
Personal E-mail:eng.mohamednazeeh@hotmail.com
Oﬃce: (502) 852–4032
Cell: (502) 797–1805

Current Research Interest

I am a graduate student at Electrical and Computer Engineering Department at the University of Louisville, Louisville, KY, USA. My general research interests are in digital
image processing, medical imaging, and computer vision. In August 2014, I have joined
the BioImaging Lab and have actively been working on developing a novel computer-aided
diagnostic (CAD) systems for early detection of acute renal transplant rejection from 4D
diﬀusion-weighted MRIs. This research includes developing new computer aided diagnostic systems, image modeling, and image segmentation and registration.

100

Education
2016 M.Sc., Electrical and Computer Engineering Department, Speed School of
Engineering, University of Louisville, Louisville, KY 40292
M.Sc. Thesis: A Non-Invasive Diagnostic System for Early Assessment of
Acute Renal Transplant Rejection- Prof. Ayman S. El-Baz, Thesis Advisor.
GPA = 4.0 (Graduation date: Summer 2016)
2009 B.Sc., Computers Engineering and Control Systems, Mansoura University,
Mansoura 35516, Egypt.
Sr. Project: Remote Controlling of Moving Objects Via Mobile or Fixed
Phones- Prof. Aly El-Desouky, Project Supervisor.
GPA = 4.0 (Graduated with excellence with honor and ranked the first in a
class of 200)

Experience
Fall 2014–Present

Graduate Research Assistant, BioImaging laboratory, Department of
Bioengineering, University of Louisville, Louisville, KY 40292, USA.

2010–2014

Graduate Research Assistant, Department of Computers Engineering
and Control Systems, Mansoura University, Mansoura 35516, Egypt.

101

Teaching/Administration Experience

Assist in teaching, laboratory demonstration, conducting tutorials, grading, and senior
graduation projects of the following Electrical Engineering undergraduate courses:

Place

Course Subject

Semester/Year

Mansoura University

Artificial Neural Networks

2010-2014

Artificial Intelligence
Machine Learning
Fuzzy Control Systems
Advanced Control Systems
Digital Control Systems
Computer Architecture
Computer Maintenance
Supervision support for an
undergraduate final project (Smart
Mansoura University

2012-2013
Modern Automatic Control
Restaurant trend) using PAC
Summer trainer for undergraduate

Mansoura University

student on Matlab basic tools and

2011-2012

PAC controller
Supervision support for an
undergraduate final project (Smart
Mansoura University

Gate) using image processing
techniques; specifically, face
recognition

102

2010-2011

Professional Aﬃliations and Memberships

• Young Professional Member, Institute of Electrical and Electronics Engineers (IEEE).
• Member, IEEE Signal Processing (SPS) Society.
• Member, IEEE Engineering in Medicine and Biology (EMBS) Society.
• Member, IEEE Biometrics Council.
• Member, IEEE Sensors Council.
• Member, IEEE Nanotechnology Council.
• Member, IEEE Electronic Design Automation Council.
• Member, IEEE Cloud Computing Community.
• Member, IEEE Systems Council.
• Member, Egyptian Engineers Syndicate, Electrical Engineering.

Awards and Recognition

• Merit of Excellence Certificate from Graduate Student Council (GSC) at the University of Louisville, in the area of community engagement in Graduate Student Regional Research Conference (GSRRC), April 2016.
• One of The Best 39 papers in the International Symposium on Biomedical Imaging:
From Nano to Macro, Prague, Czech Republic, April 16–20, 2016 (ISBI’16).
• IEEE Signal Processing Society (SPS) Travel Award 2015 to attend the IEEE International Conference on Image processing, Quebec City, Canada, September 27–30,
2015 (ICIP’15).
• GSC at the University of Louisville Travel Award 2015.
• Theobald Scholarship Award in the Electrical and Computer Engineering Department, Speed school of Engineering, University of Louisville, 2015.
• Discretionary Certificate for distinct participation in student activities (Robocon
Competition supervision), 2009–2010.

103

• Higher Education Enhancement Project Fund Discretionary Certificate for distinct students in the Department of Communications and Electronics Engineering for
Excellent grade ranked third in the second undergraduate year of education, Mansoura University , 2005–2006.

Class Work Grade

A total of 30 credit hours in Electrical Engineering and Bioengineering subjects with a
cumulative GPA of 4. Particular course concentration has been in medical image analysis
and machine learning.

Research Activities

• Image modeling, 2D and 3D image segmentation and registration.
• Development of computer-aided diagnostic (CAD) system using diﬀusion-weighted
magnetic resonance imaging (DW-MRI) for the early assessment of acute renal transplant rejection.
• Development of a CAD system for the early detection of diﬀerent types of kidney
rejection using DW-MRIs.
• Development of a cascaded two-stage CAD system for diﬀerentiating nonrejection
renal transplants from transplanted kidneys with abnormalities using DW-MRIs and
then, classifying abnormal kidney transplants into early rejection and other kidney
diseases including: tubular inflammation, acute tubular injury, graft amyloidosis, and
acute tubular necrosis.
• Assisted in grants writing and preparing primary results for the BioImaging Lab,
University of Louisville.

104

Out of Reach Connectivity

• I have trained one of the high school students during Fall and Spring of 2015 and we
had two published conference papers.
• I have trained one of the middle school students during Fall and Spring of 2016 and
we had one published conference paper.

Publications

During Fall 2014–Summer 2016, I have authored or co-authored 2 journal articles, 1 book
chapter, 6 peer-reviewed conference papers, 1 abstract in proceedings. The first article
have been submitted to Medical Image Analysis Journal (5-year impact factor 4.950); current status (under-review) and the second one to be submitted to The Egyptian Journal of
Radiology and Nuclear Medicine. The conference papers were reported as top-rank international conferences in medical imaging, image processing, and pattern recognition e.g.,
MICCAI, ISBI, and ICIP with acceptance rate less than 30%.

• Journal Articles (Total = 2)
1. M. Shehata, F. Khalifa, A. Soliman, E. Hossini-Asl, M. Abou El-Ghar, A. C.
Dwyer, G. Gimel’farb, R. Keynton, and A. El-Baz, ” Computer-Aided Diagnostic
System for Early Detection of Acute Renal Transplant Rejection Using DiﬀusionWeighted MRI,” Medical Image Analysis, 2016 (under-review).
2. E. Hollis, M. Shehata, F. Khalifa, M. Abou El-Ghar, T. El-Diasty, G. Gimel’farb,
and A. El-Baz, ”Towards Non-invasive Diagnostic Techniques for Early Detection
of Acute Renal Rejection: A Review,” The Egyptian Journal of Radiology and
Nuclear Medicine, 2016 (to-be-submitted).
• Book Chapters (Total = 1)

105

1. M. Shehata, F. Khalifa, A. Soliman, A. Taki Eldeen, M. Abou El-Ghar, T. ElDiasty, A. El-Baz, and R. Keynton, “An appearance-guided deformable model for
4D kidney segmentation using diﬀusion MRI,” Biomedical Image Segmentation:
Advances and Trends, A. El-Baz, X. Jiang, and J. Suri, Eds, Taylor & Francis,
2016, ch. 12, pp. 269–283.
• Peer-Reviewed Conference Proceedings (Total = 6)
1. M. Shehata, F. Khalifa, A. Soliman, R. Alrefai, M. Abou El-Ghar, A. C. Dwyer, R.
Ouseph, and A. El-Baz, “A Novel Framework for Automatic Segmentation of Kidney from DW-MRI,” In: Proceedings of IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI’15), New York, USA, April 16–19, 2015,
pp. 951–954.
2. M. Shehata, F. Khalifa, A. Soliman, R. Alrefai, M. Abou El-Ghar, A. C. Dwyer, R.
Ouseph, and A. El-Baz, “A Level Set-Based Framework for 3D Kidney Segmentation from Diﬀusion MR Images,” In: Proceedings of International Conference on
Image Processing (ICIP’15), Quebec, Canada, September 27–30, 2015, pp. 4441–
4445.
3. M. Shehata, F. Khalifa, A. Soliman, A. Takieldeen, M. Abou El-Ghar, A. Shaﬃe,
A. C. Dwyer, R. Ouseph, A. El-Baz, and R. Keynton, “3D Diﬀusion MRI-Based
CAD System for Early Diagnosis of Acute Renal Rejection,” In: Proceedings of
IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI’16),
Prague, Czech Republic, April 13–16, 2016, pp. 1177–1180. (Selected as One of
the Best 39 papers from around 340 accepted papers).
4. F. Khalifa, A. Soliman, A. Takieldeen, M. Shehata, M. Mostapha, A. Shaﬃe, R.
Ouseph, A. Elmaghraby, and A. El-Baz, “Kidney Segmentation from CT Images
Using A 3D NMF-Guided Active Contour Model,” In: Proceedings of IEEE International Symposium on Biomedical Imaging: From Nano to Macro (ISBI’16),
Prague, Czech Republic, April 13–16, 2016, pp. 432–435.
5. M. Shehata, F. Khalifa, E. Hollis, A. Soliman, E. Hosseini-Asl, M. Abou El-Ghar,

106

M. El-Baz, A. C. Dwyer, A. El-Baz, and R. Keynton, “A New Non-Invasive Approach for Early Classification of Renal Rejection Types Using Diﬀusion-Weighted
MRI,” In: Proceedings of International Conference on Image Processing (ICIP’16),
Phoenix, Arizona, USA, September 25–28, 2016 (In Press). (Selected for Oral Presentation).
6. M. Shehata, F. Khalifa, A. Soliman, M. Abou El-Ghar, A. C. Dwyer, G. Gimel’farb,
R. Keynton, and A. El-Baz, “A Promising Non-Invasive CAD System for Kidney
Function Assessment,” In: Proceedings of Medical Image Computing and Computer Assisted Intervention (MICCAI’16), Athens, Greek, October 17–21, 2016 (In
Press).
• Abstracts Published in Proceedings (Total = 1)
1. M. Shehata, F. Khalifa, A. Soliman, M. Abou El-Ghar, A. C. Dwyer, R. Ouseph,
and A. El-Baz, “Early Assessment of Acute Renal Rejection,” In: Proceedings of
12th Annual Scientific Meeting of American Society for Diagnostics and Interventional Nephrology (ASDIN’16), Phoenix, Arizona, USA, February 19–21, 2016.
• Patents and Disclosures (Total = 1)
1. A. El-Baz, A. C. Dwyer, R. Ouseph, F. Khalifa, A. Soliman, M. Shehata, “COMPUTER AIDED DIAGNOSTIC SYSTEM FOR CLASSIFYING KIDNEYS,” US
Non-Provisional Patent Publication 20150286786, October 8th , 2015.

Graduate Advisor
Dr. Ayman S. El-Baz, Department of Bioengineering, University of Louisville, KY.

Personal Skills, Hobbies, and Activities
• Active, self-motivated, ability to work alone and in a team, ability to work under
pressure, Internet browsing, reading, swimming, and football.

107

